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Background: The health inequalities faced by people with intellectual disabilities 
(ID) are well documented, affecting both duration and quality of life. Painful health 
conditions can be difficult to recognise as many people with ID struggle to self-report 
their pain. Therefore it is important that accurate observational tools are available to 
support recognition and assessment of pain in people with ID. 
Aim: This thesis seeks to assess the use of currently available observational 
assessments of pain through meta-analytic methods, and then evaluates a more 
specialist observational tool designed to detect gastric pain. 
Meta-analysis: A comprehensive review of the literature found 62 distinct 
observational measures used in published research. The five most commonly used 
measures were assessed through a series of meta-analyses, synthesising 
correlations between observational and self-report measures of pain. Moderate  
correlations were found for all observational measures compared to self-report, 
though unacceptable levels of heterogeneity were also identified. Recommendations 
are made for use of the Face, Legs, Activity, Crying, Consolability scale. 
Empirical paper: The Gastric Distress Questionnaire (GDQ) is a parent report 
measure designed to screen for Gastro-oesophageal Reflux Disease (GORD), a 
painful health condition which is common in people with ID. Significant differences in 
GDQ scores were found between children with and without recent GORD. A clinical 
cut off is recommended for the use of the GDQ to screen for reflux.  Behavioural 
observation by a naïve observer was not found to associate to GDQ scores provided 
by a parent, emphasising the importance of caregiver report in identifying GORD. 
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CHAPTER ONE, LITERATURE REVIEW:  
OBSERVATIONAL ASSESSMENTS OF PAIN IN CHILDREN AND ASSOCIATION 





Background: Due to the subjective nature of pain, self-report is widely accepted as 
the gold standard assessment, even in young children. However, there are many 
people who cannot give self-report ratings for pain. When self-report is not feasible, 
observational measures are often used to provide a proxy rating of pain. This review 
and meta-analysis seeks to explore the use of observational measures of pain in 
children in the research literature, and to evaluate their validity through correlation to 
self-report.  
Method: Five databases were searched, yielding an initial return of 18335 papers. 
Once the papers had been screened, 526 studies were identified that reported pain 
scores obtained from observational measures in children aged 1-18 years. A series 
of meta-analyses were conducted to synthesise published findings on the 
associations between any of the five most common measures and self-report of pain. 
Results: Sixty two different measures were identified, but 346 of the reviewed 
papers reported using either the Children’s Hospital East Ontario Pain Scale 
(CHEOPS; McGrath et al., 1985), the Visual Analogue Scale (VAS; Price, McGrath, 
Rafii & Buckingham, 1983), the Face, Legs, Activity, Crying and Consolability 
(FLACC; Voepel-Lewis, Shayevitz & Malviya, 1997), the Observer Pain Scale (OPS; 
Hannallah et al., 1987), and the Wong-Baker Faces Scale (WBF; Wong & Baker, 
1988). All five of the measures were found to have a moderate correlation to self-
report. 
Conclusion: There is an excess of observational measures being used in the 
research, without sufficient evidence to support their use. The FLACC is 
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recommended as a useful structured assessment of pain with moderate correlation 



















Acute pain is widely considered to be the human body’s “warning signal”, 
typically triggered by injury or disease (Loeser & Melzack, 1999). Pain is a universal 
human experience that all children will experience many times as they grow and 
learn about the world. In their early years, most children undergo many painful 
routine medical procedures such as vaccination, and a substantial minority will also 
undergo other painful procedures such as surgery. There is a drive in the medical 
literature to develop procedures that are less painful, and to improve the efficacy of 
pain management (Stinson et al., 2008). However, the improvement of procedures, 
and the success of routine pain management is dependent upon recognition and 
accurate assessment of pain (Verghese & Hannallah, 2010). 
Accurate assessment of pain is a complex process. Current models of pain 
recognise pain as subjective, being influenced by psychological components of 
cognition and emotion, such as anxiety, expectations and context, and early 
experience of injury (Merksey, 1991; Craig, 2009). Given the subjective nature of 
pain, self-report is the preferred method of pain assessment in adults and for 
children as young as three years old (Royal College of Nursing, 2009). However, not 
all children are able to engage with self-report measures. Self-report of pain requires 
an understanding of the concept of pain, an ability to identify and label internal states, 
and a comprehension of magnitude and serial order (Fanurik, Koh, Harrison, Conrad 
& Tomerun, 1998). Young children and children with cognitive impairment, 
communication impairments, or those in temporary states of distress or confusion 
may be unable to provide accurate self-reports of pain (Voepel-Lewis, Malviya & Tait, 
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2005). The consequences of failing to recognise pain can be severe. Experiences of 
pain have been connected, even in the short term, to reduced affect and an 
increased need to aggress (Riva, Wirth & Williams, 2011). In people with cognitive 
impairments, untreated pain is associated with behaviours that challenge, in 
particular self-injurious behaviour (Carr & Owen-DeSchryver, 2007), which can have 
a significant negative impact on quality of life (Beadle-Brown, Murphy & DiTerlizzi, 
2009). It has also been proposed that whilst self-report is an important tool to capture 
a subjective experience, it is merely one aspect of a more complex behavioural 
response to pain (Anand & Craig, 1996). Thus, despite self-report being identified as 
the gold-standard of pain assessment, it is neither adequate nor appropriate in all 
cases. 
In cases where self-report is not feasible or appropriate, pain assessments 
are frequently carried out based upon the judgements of others. Von Baeyer & 
Spagrud (2007) describe four primary groups of observational pain tools applied in 
research and clinical practice. ‘Behavioural checklists’ and ‘behaviour rating scales’ 
both require observers to identify and/or score a series of pain related behaviours 
that may be observed in the child in question, to produce a total score indicative of 
pain intensity. ‘Global behaviourally anchored rating scales’ also make use of 
behavioural indicators, but descriptions of behaviours are given only as examples to 
guide the rating, observation of specific behaviours is not rated or required to justify 
a rating. Finally, ‘global rating scales’ require the observer to provide a rating of pain 
based on their own judgement without any reference to specific behaviours. Global 
rating scales appear to rely upon the implicit human ability to recognise pain in 
others and, despite being widely used, they have been criticised for being 
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oversimplified and failing to capture the complexity of the pain response (Williams, 
Davies & Chaudry, 2000). Given the range of observational tools available, and the 
application of such tools as a proxy rating when a person is unable to self-report 
(e.g., young children, children with cognitive impairment), it is essential that the 
validity of these observational measures is evaluated. 
Despite their widespread use, there is a lack of synthesised evidence regarding 
the psychometric properties of many common observational measures used to 
assess pain in children.  A systematic review of observational measures of pain 
conducted by Von Baeyer and Spagrud (2007) identified only seven measures that 
were deemed to have sufficient evidence of validity and reliability to warrant 
recommending for use in clinical trials. However, a more recent systematic review by 
Andersen, Langius-Eklöf, Nakstad, Bernkley and Jylli (2017) identified a total of 65 
observational assessments of pain cited across twelve published reviews of the 
research literature. Thus, there is inconsistency between the practice that is 
supported by evidence and the measures that are reportedly being used in current 
research. These data require reviewing and statistical synthesis to evaluate and 
improve current practice. Meta-analytic methods have not yet been applied to this 
literature. A synthesis of the available data regarding putative associations between 
observational methods and self-report will enhance the understanding of the validity 
of tools in current use. 
Therefore, the present study seeks to extend the literature by providing 
quantitative evaluation of the use of observational pain assessments for children in 
published research, addressing two key aims: 
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1. To identify the most common observational assessments used in published 
studies that seek to quantify pain in children 
2. To evaluate the validity of the most common observational assessments, by 
evaluating the association between pain scores obtained by observation and 
those obtained by the gold standard method, self-report. 
1.3. Method 
1.3.1. Literature Search 
Ovid PsycInfo, Medline, Embase, Web of Science and CINAHL databases 
were searched for articles relating to the assessment of pain in children on 15th 
January 2018, using the search terms outlined in Table 1. As the aim of the initial 
search was to identify all research papers which made use of observational 
measures of pain, the search terms were broad. The search was restricted to the title 
and abstract and the terms relating to “pain” and “scale” were specified to be no 
more the three words apart from each other. Terms referring to “observation” or 
“behaviour” were not used for the initial search because a preliminary review of the 
literature identified that many papers used terms such as “pain scales” in the title or 
abstract and only clarified the use of observational scales in the body of the paper. 





Table 1: Search terms used to identify papers relevant to pain assessment in 
children, applied to Ovid PsycInfo, Medline, Embase, Web of Science and CINAHL 
databases. 
Construct Search terms 
Pain Pain*; Discomfort 
Scale Measure*; Scale*; Test*; Rating*; Assess*; Checklist* 
Child Child*; Adolescen*; Youth*; Infan*; Teen*; Juvenile*; Paediatric*; 
Pediatric* 
1.3.2. Inclusion Criteria 
After duplicates were removed, titles and abstracts were reviewed to identify 
papers that met exclusion criteria. To maintain the breadth of the search and avoid 
premature exclusion of potentially useful papers, any papers that did not explicitly 
meet one or more exclusion criteria were retained to be screened at full paper stage. 
This approach was taken as a strategy to address poor reporting of samples in paper 
abstracts, for example, in many cases the age range of the sample was not reported 
in the abstract and therefore it was impossible to determine if studies met the 
inclusion criteria for age until the paper had reached full screen. In the initial paper 
screening the methodology and results sections were reviewed to identify those 
papers which met the inclusion criteria outlined in Table 2. For studies that met the 
inclusion criteria, the observational tools used, sample size, and sample age range 
were recorded. 
A second screening stage was undertaken once all reported observational 
measures of pain had been identified. Papers reporting any of the ten most 
commonly used measures were screened for their inclusion of self-report measures 
of pain, and correlation between self-report and observational pain scores. The 
number of measures entered into this screen was chosen post-hoc as together they 
accounted for the vast majority of the literature (80.98%). The number of studies 
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reporting correlations between self-report and observational pain scores was used to 
judge the feasibility of meta-analysis for each measure and determine which 
measures to include in the final meta-analysis.
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Table 2: Inclusion and exclusion criteria applied to literature search at title and abstract screening, screening of methodology and 
results, and screening of full text for selection of primary studies for meta-analysis 
Inclusion Criteria Justification Exclusion criteria 
Initial literature search – (i) title  and abstract screening; (ii) initial screening of methodology and results 
Assessment of pain   
Methodology refers to a rating of pain 
intensity that is obtained by an 
observer. If a measure is cited which 
may be used either as self-report or 
observer report, the wording 
describing who makes the rating 
must be clear and unambiguous. 
 
This is to ensure that studies 
using only self-report of pain 
are not included in error. 
Specialist measures were 
excluded so as to restrict the 
search to the measures with 
the broadest application and 
relevance. 
Pain only assessed by self-report 
 Only pain measures reported are described as “subjective” or being 
obtained through self-report 
 Only pain measures reported are typically self-report measures e.g. Wong 
Baker Faces scale, with no explicit clarification given that score was 
determined through observation rather than self-report 
Specialist measure 
 Use of a measure that is designed to assess the pain associated with a 
specific health condition 
 Use of a measure that is designed to assess pain in one specific body 
part or region 
It must be clearly established that 
there is reason to believe the child is 
experiencing acute pain; the cause of 
pain should be established and 
described in the methodology 
 
This is to limit the chances 
that the assessment of pain is 
being confounded by other 
emotional states such as 
anxiety or distress. 
Pain not an outcome measure 
 No attempt to quantify intensity of pain 
 Assessment of associated construct e.g. distress or anxiety rather than 
pain 
 No description given of painful procedure or incident to justify assessment 
of acute pain 
Observational assessment used as an outcome measure  
The observational measure of pain 
must be referenced in the results 
section of the study 
 
 
This is to maintain the aim of 
the review in reviewing tools 
used as research measures, 
by excluding studies that cite 
the use of measures only as 
part of routine clinical practice 
without conducting any 
analysis of the ratings 
Pain not an outcome measure 




Inclusion Criteria Justification Exclusion criteria 
obtained.  
Pain in children   
The pain is being observed in healthy 
human subjects who are between 
one and eighteen years of age 
 
To maintain the focus of the 
review which is pain in 
children, and not potentially 
confound results with pain 
measures intended for infants 
or adults. 
No participants <18 years 
 Sample age range is all above 18 years 
 Participants are explicitly described as “adult” 
No participants >12 months 
 Sample age range is below 12 months 
 Participants are explicitly described as “newborn” “neonates” or 
“infants” 
Unable to extract data for 1-18 year olds 
 Sample includes children and adults, or children and infants, but is not 
stratified by age in results section 
 Either upper or lower age limit is not given making it impossible to 
ascertain age range of sample 
Chronic pain/health problem 
 Sample selected for chronic, functional, or recurring pain 
 Sample selected for chronic health problem associated with pain e.g. 
arthritis, fibromyalgia, cancer 
Non-human subjects 
 Animal studies 
Research literature   
The study is a quantitative or mixed 
methodology empirical study 
published in English in a peer 
reviewed journal 
To maintain the focus of the 
review on use of measures in 
the research literature. 
Not in English language 
 Full text is not available in English 
Not a quantitative empirical paper  
 Case study 
 Qualitative study 
 Commentary 
 Dissertation 
 Protocol for proposed study 




Inclusion Criteria Justification Exclusion criteria 
 
Review/meta-analysis 
 Cochrane review 
 Narrative literature review 
 Other synthesis of literature 
Meta-analysis – full text screening  
Chosen observational measure  
The study includes one of the chosen 
frequently used observational 
measures, as identified by the 
literature search and second screen 
To ensure the meta-analysis 
is conducted on the 
observational measures that 
are most commonly reported 
in research 
No chosen measure 
 None of the  measures chosen for meta-analysis are reported in the 
results section of the study 
Self-report data   
A self-report measure of pain is 
applied to children aged three years 
or older, assessing the same children 
and same incident of pain as the 
observational measure 
To ensure that there is a valid 
measure of self-report to 
compare against. The cut-off 
of three years is based on the 
recommendations for clinical 
use of self-report scales 
(Royal College of Nursing, 
2009). 
No self-report 
 No self-report data reported 
 Self-report not made independently 
 Self-report scores reported from sample under years of age 
 Self-report measures are applied to a different group of children than 
observational measure 
 Self-report was applied at a different time point than observational 
measure 
Correlation    
The results of a correlation analysis 
between the observational measure 
and the self-report measure of pain is 
reported by the study 
For the purposes of the meta-
analysis a correlation was 
required as the assessment of 
association between 
observation and self-report 
scores of pain 
No correlation 
 Study does not report a correlation analysis between self-report and 
observational assessments of pain 
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The initial search returned 18335 articles. The full results of the screening 
process are presented in Figure 1 in accordance with PRISMA guidelines for 
conducting and reporting systematic reviews and meta-analyses (Moher, Liberati, 
Tetzlaff & Altman, 2009). Initial removal of duplicates and papers which could not be 
found or accessed left a total of 9722 papers for title and abstract screening.  
The most common reasons for exclusion at abstract screening were that the 
paper was not a quantitative research study (n = 2449), or that it used only self-
report measures in the assessment of pain (n = 1013). The remaining 2244 articles 
had their methodology and results reviewed in more detail against the inclusion and 
exclusion criteria. Articles reporting a literature review or meta-analysis that used 
similar inclusion criteria to the current study, specifically regarding age ranges and 
use of observational measures, were screened for any papers that had been missed 
from the original search. Although three additional papers were identified through 









1.3.2.1. Quality rating. 
The quality rating framework presented in Table 3 was developed to assess 
the quality and risk of bias within the literature. The framework assessed quality 
across five domains; sample selection, induction of pain, observer blinding, use of 
observer scale, and use of self-report scales. All domains were rated on a likert scale 
from 0 - 3 with 3 indicating the highest level of quality and methodological rigour. The 
quality rating score was obtained by summing the obtained values and dividing the 
sum by the maximum potential score of 15, thereby producing a quality score 
between zero and one, with one indicating a primary study which achieved ratings of 
high quality in all domains. 
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Table 3: Quality rating framework applied to primary studies in order to calculate quality index scores for quality weighted analysis 
Domain 0 Unable to rate 1 Low quality 2 Moderate quality 3 High quality 
Sample 
selection 
Clinic or setting 
not identified 
Single restricted/non-random 
sample e.g. specialist clinic 
Multiple restricted/non-random 
samples e.g. multiple clinics 




exclusion criteria  
Cause of pain named or 
described, but multiple causes of 
pain/procedural variations 
grouped together in reporting 
correlation. 
Specific painful procedure 
outlined, or multiple procedures 
with correlations separated by 
procedure. Multiple clinicians or 
teams administering procedure, or 
clinician/team not described. 
Painful procedure clearly outlined 
and administered by a single 
clinician or team (where multiple 
clinicians are required for 
procedure). In cases of multiple 
procedures either all procedures 
administered by same 
clinician/team or distinct 
clinician/team per procedure as 





No description of 
how rating was 
made / rater not 
identified. 
Pain assessed by person with 
knowledge of experimental 
condition or self-report scores, or 
person administering procedure. 
 
Pain assessed by rater(s) blinded 
to self-report scores and 
experimental condition (if 
appropriate). 
Pain assessed by rater(s) blinded 
to self-report and experimental 
condition, in addition to at least one 





N/A – meets 
exclusion criteria 
Study does not describe any 
evidence supporting use of the 
tool as an observer measure. 
Study describes evidence base for 
use of tool as observer measure 
but not pertaining to use in 
described sample. 
Study clearly describes evidence 
justifying use of tool as an observer 






given with no 
description of 
how they were 
obtained. 
Use of own measure, or 
measure described but not cited. 
Study describes evidence base for 
use of tool as a self-report 
measure but not pertaining to use 
in described sample. 
Study clearly describes evidence 
justifying use of self-report measure 
in described sample and/or 
describes procedure to endure 




1.3.2.2. Data extraction. 
The results of reported correlation analyses between the self-report and 
observational rating tool were extracted from primary studies. A protocol for data 
extraction was developed to ensure consistent decisions were made regarding the 
choice of correlation values in studies where multiple correlations were reported. The 
reliability of data extraction was assessed using a 20% random sample. A research 
assistant independently extracted correlation values in accordance with the protocol 
and retrieved the same values as the author in all cases.  Where a primary study 
reported relevant correlations for multiple subsamples of different age groups 
containing unique participants, both were extracted and entered separately into the 
synthesis. 
1.3.2.3. Analysis strategy. 
To meet the first aim of the current study, the methodology and results of all 
papers meeting the literature review inclusion criteria were reviewed to extract the 
observational measures used. The details of each named observational measure 
were recorded. The number of uses of each named measure was recorded to 
calculate which measures were reported most frequently in the literature. After the 
five most frequently used measures had been determined, all papers were reviewed 
using the meta-analysis inclusion criteria (Table 2), those meeting inclusion criteria 
underwent quality rating and data extraction. The top five measures were selected 
for further analysis because together they represented approximately two-thirds 
(66.57%) of the reviewed literature. Given that only a small portion of the reported 
studies were likely to meet the further inclusion criteria for the meta-analysis, it was 
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thought unlikely there was a sufficient wealth of data for a meta-analytic approach to 
be worthwhile when applied to measures other than the five most commonly used. 
The extracted correlation scores were recorded as Pearson’s r correlation 
coefficients. Where studies reported using nonparametric approaches such as 
Spearmans Rho or Kendall’s Tau, then the Pearson coefficient was approximated 
using the transformations reported by Rupinski and Dunlap (1996).  
Meta-analyses were conducted using the random-effects model. The random-
effects is used to estimate the mean of a distribution of possible correlations. It is 
accepted that true variation may occur due to the idiosyncratic characteristics of the 
individuals being studied or the unique circumstances of experimental procedure. In 
contrast to a fixed-effect model, small n studies are not discounted based on sample 
size alone, nor are large n studies necessarily given a larger weighting. Since each 
study provides information about the correlation between observation and self-report 
in a unique sample and a unique set of procedures, the goal of the synthesis is to 
capture all of the available effect sizes that describe these difference contexts, 
without allowing any single study to assert disproportionate influence over the final 
estimate. Given the variations in methodological procedures and in sample 
characteristics that were observed in the primary studies, it is highly unlikely that all 
the studies were measuring the same effect to the same precision. Therefore it was 
not appropriate to assume a common effect size across all studies, hence the use of 
a random-effects model rather than a fixed-effects model. 
As an additional exploration of the effects of the quality of the included studies 
on the synthesis, the quality-effects model was also calculated. The quality effects 
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model (Doi & Thalib, 2008) extends the random effects model by explicitly including 
rating of methodological quality in addition to the size of the sample in the estimation 
of precision. In this review the quality effects model was calculated using the total 
score from the quality framework outlined in Table 3. The quality effects model can 
be interpreted as the meta-analytic synthesis that would have been obtained had all 
of the studies been of the same methodological quality as the best study in the 
review. Accordingly, the quality effects model provides a measure of attrition 
attributable to methodological variation.  
Within the calculation of the random-effects model, the DerSimonian and 
Laird method (DerSimonian & Laird, 1986) was applied to calculate the between 
studies variation (tau). Due to the variation in the reported methodology of the 
included studies, it was important to assess heterogeneity in the meta-analysis. A 
heterogeneous effect refers to distributions of effects in the primary studies that are 
too great to be idiosyncratic variation in the correlation between observation ratings 
of pain and self-report. These may reflect measurement error, individual differences 
within the sample, or methodological variation in study procedures. Cochrane’s Q 
was also applied to the analysis of heterogeneity, it is a computation based upon the 
deviation of each effect size from the mean of all studies. If the Q value is significant 
at alpha < .01 then there is definite evidence of heterogeneity. In the current review 
the Higgins I2 statistic was the primary calculation used to define the cut off for 
“problematic heterogeneity”. Higher I2 values indicate variation in effect that cannot 
be attributed to true variation in the distribution of effect in the population. The 
threshold for defining problematic heterogeneity in the current review was defined as 
a Higgins I2 value greater than 75%. A high threshold for problematic heterogeneity 
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was determined appropriate due to both the considerable variation observed in the 
methodologies of the primary studies, and the subjective nature of pain ratings.  
In cases of problematic heterogeneity, a leave-one-out analysis was 
conducted to identify primary studies that exerted a disproportionately influential 
effect on the meta-analytic synthesis. If omitting a study resulted in an effect outside 
of the 95% CI for the complete meta-analysis then that study was deemed to have a 
disproportionate influence. The study was excluded and the synthesis was repeated.  
Subgroup analyses were applied to all meta-analyses with a sufficient number 
of primary studies, to attempt to explore potential sources of heterogeneity across 
the studies. Differences in the weighted estimates between groups of studies was 
calculated using Cochrane’s Q. 
Publication bias and small study effects were explored through visual and 
statistical inspection of the funnel plot. A funnel plot is a scatterplot of the observed 
effects from each of the primary studies against a measure of study precision. A 
funnel plot provides a method of detecting systematic heterogeneity. The assumption 
is that studies with high precision will be plotted near the average provided by the 
meta-analytic synthesis, whereas studies with low precision will be spread evenly on 
both sides of the average, creating a roughly funnel-shaped distribution. Studies that 
fall outside of the desired ‘funnel’ suggest the presence of publication bias in the 
group of primary studies. A trim and fill procedure (Duval & Tweedle, 2000a; Duval & 
Tweedle, 2000b) was applied to any meta-analysis in which publication bias was 
identified. The trim and fill procedure builds on the assumption that publication bias 
would lead to an asymmetrical funnel plot. An iterative algorithm was applied to the 
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data to remove the most extreme small studies from the side of the funnel plot, re-
computing the effect size at each iteration until the funnel plot is symmetric. In 
theory, the trim and fill procedure yields an unbiased estimate of the effect size. 
However, the trim and fill procedure also reduces the variance of the effects, yielding 
a too narrow confidence interval. Therefore, the algorithm then adds the original 
studies back into the analysis and imputes a mirror image for each. Because the 
funnel plot method is based on an assumption of normal distribution of data points, it 
was not applied where the synthesis revealed unacceptable levels of heterogeneity. 
An additional exploration of the effects of publication bias was achieved 
through the calculation of the fail-safe N (Rosenthal, 1979). The fail-safe N provides 
an estimation of how many non-significant studies would be required for the 
observed effect to no longer be significant. A large fail-safe N suggests that the 











1.4.1. Observational Assessments of Pain in the Literature 
To address the first aim of the study and explore the use of observational 
tools reported in the research literature, a systematic search of six databases was 
conducted, and reported observational tools were extracted.  
The measures used in the 526 papers that met inclusion criteria were 
recorded and are presented in Table 4. Variations of measures such as the Modified 
Children’s Hospital of East Ontario Pain Scale (mCHEOPS; Splinter, Semelhago, & 
Chou, 1994) were grouped with the original measure where the original measure 
was clearly identifiable or named. In the case of the various different faces scales, 
faces scales were reported separately due to the use of different graphics or images 
for the faces. 
Across the 526 papers reviewed, a total of 62 observational measures were 
identified.  However, 46 of the identified measures were reported in fewer than ten 
papers each, and 29 were reported in only one paper each. Thirteen papers were 
reviewed which did not reference an observational measure, but instead described 
an observation based assessment designed specifically for the purposes of their 
study. The category of “Study specific measure” was not used if the measure was 
also found referenced in other reviewed papers i.e. if it was the first paper to publish 
a measure which went on to be more widely used. Only eight measures could be 
found that were reported in more than 20 papers each, and three of those eight may 
be better referred to as techniques rather than as published measures. The Visual 
Analogue Scale (VAS), Numerical Rating Scale (NRS), and Categorical Rating Scale 
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(CRS) are all variations of global rating scales which use linear, numeric scales or 
categories such as “mild/moderate/severe” to rate pain. Although there are some 
published measures which incorporate these rating techniques, for the purposes of 
the current review, a paper was categorised as using a VAS, NRS or CRS if the 
technique was used in isolation with no guidance as to which behaviours to use to 
determine the final rating.  
The five most commonly reported measures were the Children’s Hospital East 
Ontario Pain Scale (CHEOPS; McGrath et al., 1985), the Visual Analogue Scale 
(VAS; Price, McGrath, Rafii & Buckingham, 1983), the Face, Legs, Activity, Crying 
and Consolability (FLACC; Voepel-Lewis, Shayevitz & Malviya, 1997), the Observer 
Pain Scale (OPS; Hannallah et al., 1987), and the Wong-Baker Faces Scale (WBF; 
Wong & Baker, 1988). The majority of the 526 reviewed papers reported using one 
or more measures from the five most commonly reported measures (k1 = 346). Of 
the 346 papers which reported using one of the five most common measures, only 
32 met the further inclusion criteria (see Table 3) required to be included in the meta-
analytic stage of the review. Further detail on the measures and on the 32 primary 
studies reporting an association between those measures and self-report of pain can 
found in the meta-analyses presented in section 1.3.3. 
 
                                            
1
 k is used to denote number of published studies 
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Table 4: Measures extracted from final paper sample with frequency (k) of use in the 
literature. Frequency totals more than 526 due to use of multiple measures in many 
of the studies reviewed. 
Name of measure 2 Authors  k 
Children's Hospital of East Ontario Pain Scale McGrath et al. (1985) 121 
Visual Analogue Scale Multiple versions described 87 
Face Legs Activity Crying Consolobility Scale Voepel-Lewis et al. (1997) 81 
Objective Pain Scale  Broadman et al. (1988) 71 
Wong & Baker FACES scale Wong & Baker (1988) 26 
Children's and Infants’ Postoperative Pain Scale Büttner & Finke (2000) 24 
Categorical Rating Scale  Multiple versions described 24 
Numerical Rating Scale Multiple versions described 22 
Parents Postoperative Pain Measure Chambers et al. (1996) 18 
Toddler Preschooler Postoperative Pain Scale Tarbell et al. (1992) 15 
Faces Pain Scale Bieri et al. (1990) 13 
Study specific pain assessment described without measure being named or cited 13 
Sound, Eye and Motor scale Wright et al. (1991) 12 
Modified Behaviour Pain Scale Taddio et al. (1995) 11 
Child Facial Coding System Gilbert et al. (1999) 10 
Faces Pain Scale-Revised Hicks et al. (2001) 10 
Maunuksela Behavioural Pain Scale Maunuksela et al. (1987) 10 
Non Communicating Child Pain Checklist Breau et al. (2002) 9 
Colour Analogue Scale McGrath et al. (1996) 4 
The COMFORT scale Ambuel et al. (1992) 4 
Maunuksela faces VAS pain scale Maunuksela et al. (1987) 4 
Procedural Behaviour Checklist LeBaron & Zeltzer (1984) 4 
Behavioural Observational Pain Scale Hesselgard et al. (2007) 3 
Behaviour Checklist Goodenough et al. (1997) 3 
Preverbal, early verbal pediatric pain scale Schultz et al (1999) 3 
University of Wisconson Childrens Hospital Pain 
Scale 
Soetenga et al. (1999) 3 
Dalhousie Everyday Pain Scale Fearon et al. (1996) 2 
Derbyshire Children's Hospital Pain Tool Unpublished 2 
Individualised Numeric Rating Scale Solodiuk & Curley (2003) 2 
Kuttner & LePage FACES scale Kuttner & LePage (1989) 2 
Nurses Assessment of Pain Index Stevens (1990) 2 
                                            
2
 Name is based on most commonly used name for measure found in the review, name has been 




Name of measure 2 Authors  k 
Objective Pain Discomfort Score Steward (1975) 2 
Pediatric Pain Profile Hunt et al. (2004) 2 
Total Quality Pain Management Foster & Varni (2002) 2 
Alder Hey triage pain score Stewart et al. (2004) 1 
AIIM Pain Discomfort Scale Brown & Fisk (1992) 1 
Baby FACS Oster & Rosenstain (1993) 1 
Behavioural Pain Scale Payen et al. (2001) 1 
Measure not named Cameron et al. (1992) 1 
Child Pain Scale Gauvain-Piquard et al (1987) 1 
Echelle Douleur Enfant San Salvador Collignon & Giusiano (2001) 1 
Facial Action Coding System Ekamn & Friesan (1978) 1 
Facial Affective Scale McGrath et al. (1996) 1 
Global Assessment of Behavioural Reaction Juniper et al. (1991) 1 
Observational Pain-Discomfort Scale Buttner et al. (1990) 1 
Hester Poker Chip Tool Hester (1979) 1 
Izard's Coding for Facial Signs of Pain Rowland et al. (1989) 1 
KKU Pediatric Pain Assessment Tool Jongudomkarn et al. (2008) 1 
Measure not named Krane et al. (1987) 1 
Multidimensional Assessment of Pain Scale Ramelet et al. (2007) 1 
Modified Pediatric Observer Pain Scale Wolf et al. (1990) 1 
Multiple Size Poker Chip Tool St-Laurent-Gagnon et al. 
(1999) 
1 
Neonatal Facial Coding System Grunau et al. (1990) 1 
Pain Behaviour Checklist Peters (2007) 1 
Pain Indicator for Communicatively Impaired 
Children 
Stallard et al. (2002) 1 
Princess Margaret Hospital Pain Assessment Tool Robertson (1993) 1 
Post Operative Pain Score Attia et al. (1987) 1 
Pain Rating Scale Joyce et al. (1994) 1 
Royal College of Emergency Medicine Composite 
Pain Tool 
Royal College of Emergency 
Medicine (2004) 
1 
Riley Infant Pain Scale Schade et al. (1996) 1 
Toddler Discomfort Index Tomlinson & Stewart (2008) 1 
Universal Pain Assessment Tool University of California (2004) 1 
Verbal Pain Score Güleç et al. (1998) 1 
1.4.2. Selection of Measures for Meta-analysis 
Papers including any of the ten most commonly reported observational 
measures of pain were screened for inclusion of any self-report measures of pain, 
and the reporting of a correlation analysis between self-report and observational pain 
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scores3. The results in Table 5 show that few data are available pertaining to the 
relationship between self-report and many of the observational measures. The top 
five most commonly reported measures were selected for meta-analysis because the 
results of the second screening suggest these measures presented sufficient data 
for a worthwhile synthesis. Although only one study could be found which reported 
on a correlation between self-report and the Objective Pain Scale (OPS), it is 
reported on below due to the frequency with which the OPS is cited in the literature. 
Table 5: The number of papers reporting the use of one of the ten most commonly 
used observational pain assessments, self-report of pain, and a correlation between 










Children's Hospital of East Ontario Pain Scale 121 31 7 
Visual Analogue Scale 87 48 15 
Face Legs Activity Crying Consolobility Scale 81 25 9 
Objective Pain Scale  71 8 1 
Wong & Baker FACES scale 26 20 7 
Children's and Infants’ Postoperative Pain Scale 24 1 0 
Categorical Rating Scale  24 11 2 
Numerical Rating Scale 22 11 3 
Parents Postoperative Pain Measure 18 8 4 
Toddler Preschooler Postoperative Pain Scale 15 1 0 
 
1.4.2. Quality Assessment of the Most Commonly Used Measures 
To address the first aim of the review and provide further assessment of the 
use of observational pain assessments in the literature, the quality of the 32 primary 
                                            
3
 At this stage of screening, the specific criteria listed in the ‘meta-analysis full review’ section of table 
2 were not applied, therefore the numbers reported in table 5 do not align with the number of primary 
studies included in the final meta-analyses.  
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studies utilising the CHEOPS, VAS, FLACC, OPS and WBF were explored in more 
detail. Quality was assessed across primary papers according to the quality 
framework presented above (Table 3).   
1.4.2.1. Sample. 
Five studies failed to report any information regarding the study setting or how 
the sample was obtained. A single point of recruitment was reported in 20 studies, 
and seven studies reported multiple recruitment sites. The largest selection of 
recruitment sites was reported by Boivin et al. (2008) who reported recruitment from 
25 GPs in the Lorraine region of France.  
1.4.2.2. Cause of pain.  
Many of the primary studies were intervention studies examining the effects of 
variations in procedure, such as changes to technique, or the effect of different 
analgesics. For the purposes of this review such variations were considered “multiple 
procedures” in the quality rating. The majority of studies were given a low quality 
rating (k = 21) because, although they often separated out the key outcome results 
by procedure, they grouped all procedures together in the reporting of the correlation 
between observer measure and self-report, meaning that the pain scores were 
related to multiple different painful procedures. Eight studies received a moderate 
quality rating, reporting specific procedures but either reporting that the procedure 
was carried out by multiple professionals, or failing to describe those responsible for 
the painful procedure. Three studies received a high quality rating, with the source of 
pain being a single, well described procedure, administered by the same person or 
team to each participant. 
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1.4.2.3. Risk of observer bias.  
The majority of studies received a low quality rating for failing to blind 
observers (k = 15). Many studies reported blinding to experimental groups, however 
there was frequently ambiguity regarding whether observers had been blinded to 
child ratings of pain, which may influence the observer rating and so was rated as 
low quality for this domain. Six studies clearly reported blinding observers from self-
report ratings and experimental groupings, and a further seven reported the addition 
of at least one other rating by another observer, further reducing the potential risk of 
bias. Four studies were categorised as “unable to rate” in this domain, as there was 
no procedure reported for obtaining observer scores beyond the naming of the 
observational tool, therefore it was impossible to determine to what extent observers 
had been blinded. Chadha et al (2013) was rated twice for this domain as the 
procedure differed according to the two measures used. In the case of the FLACC, 
which was completed by an observer, the study received a high quality rating, as 
blinding procedures were clearly described. However, in the case of the WBF, which 
was completed by a parent, there was nothing described in the procedure to suggest 
that parents had been blinded to the self-report scores provided by their children. 







1.4.2.4. Use of observation scales. 
Six studies received a high quality rating for their use of observation scales, 
describing evidence that explicitly supported the use of the named tool in the sample 
reported by the primary study. However, the majority of studies received a rating of 
moderate quality (k = 12) or low quality (k = 14). Poorest ratings in this domain were 
obtained by studies reporting use of global rating scales. Studies reporting the 
CHEOPS and FLACC fulfil criteria for a moderate quality rating simply by citing the 
measure, as the measures were originally published as observational tools. However, 
references for the VAS were rarely given at all, and the original validation of the WBF 
does not provide support for its use as an observational tool. Only two of the 
fourteen studies using the VAS as an observational tool made explicit reference to 
an evidence base supporting its validity when used in this way (Kelly et al., 2002; 
Bearden et al., 2012).  
Several of the 32 studies reported multiple observation measures, and so 
because ratings in this domain are based on appropriateness of the scale to the 
described sample, a separate rating was given based on the appropriateness of 
each relevant measure. Bringuier et al. (2009) received a high quality rating for the 
use of the CHEOPS, but only moderate quality ratings for the FLACC and OPS. 
Chadha et al. (2013) received a moderate quality rating for the FLACC, but a low 
quality rating for the WBF. Risaw et al. (2017) received a high quality rating for their 





1.4.2.5. Use of self-report scales. 
Use of self-report scales was the highest rated of the five domains, with 18 
studies receiving a high quality rating. Many studies provided justification for the 
choice of self-report with their sample. Some studies with wide age ranges used 
multiple self-report scales to ensure that appropriate scales were available for all 
participants. Studies frequently included screening procedures assessing 
comprehension of the self-report scales, or explicitly described teaching procedures 
to ensure that children understood the scales and could provide meaningful ratings. 
Only three studies failed to provide evidence to support their choice of self-report 
scale, typically because they used their own self-report scale that had no published 
evidence base. Eleven studies described some evidence supporting the choice of 
self-report scale but either failed to mention the sample used in the supporting 
studies, or explicitly described studies with samples that did not match the sample 
reported in the primary study. 
The rating of quality may reflect fundamental limitations in the measurement 
of subjective experience; however, all of the reviewed studies contain at least one 
area of potential contamination and bias on a wide range of criteria and the overall 
quality of this corpus of evidence should be considered as poor.  
1.4.3. Associations Between Observational Assessments and Self-report 
To address the second aim of the study exploring the association between the 
five most commonly used observational assessments and self-report measures of 
pain, a series of meta-analyses were undertaken, synthesising the available 
literature where studies reported a correlation between one of the five most 
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frequently used behavioural assessments and self-report measures of pain. These 
meta-analyses incorporated the ratings of study quality, as described above. 
1.4.3.1. Children’s Hospital East Ontario Pain Scale. 
The Children’s Hospital East Ontario Pain Scale (CHEOPS; McGrath et al., 
1985) is a behavioural tool which requires observers to identify and rate six 
behaviours. It has the unusual score range of 4 - 13, with scores under six indicating 
no pain. A modified version of the CHEOPS is also available which simplifies the 
scale to a 0 - 2 rating of five behaviours, resulting in a total score in the 0 - 10 range 
(Splinter, Semelhago, & Chou, 1994).  
The primary studies included in the analysis are reported in Table 6. There 
were eight primary studies reporting a total of N = 517 participants. The analysis 
included participants from the age of four to 15 years, with the majority of 
participants being under ten. The majority of studies in this analysis reported using 
variations of the faces scale for self-report (WBF, Wong & Baker, 1988; Faces Pain 
Scale Revised; FPSR, Hicks, von Baeyer, Spafford, van Korlaar & Goodenough, 
2001; Faces Pain Scale, Bieri, Reeve, Champion, Addicoat & Ziegler, 1990), with 
two studies reporting using the VAS, and one using the Oucher (Beyer, Denyes & 
Villarruel, 1992). All of the studies included in this meta-analysis reported using the 
original CHEOPS as described by McGrath et al. (1985). 
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Table 6: Methodological details and quality rating of primary studies reporting a correlation between pain scores obtained from 
CHEOPS and self-report. Details presented as reported in published paper.  














































Beyer et al. (1990) 8 3-7 0 1 2 3 3 Surgery Nurse Oucher .47 




Cassidy et al (2002) 58 5 2 1 2 3 3 Vaccination Blinded rater Faces .49 




Lee & White-Traut (1996) 126 3-7 1 1 1 2 2 Venipuncture Not named WBF .47 
Sikorova & Hrazdilova (2011) 60 5-10 1 1 0 2 2 Venipuncture  Researcher WBF .62 
Tyler et al. (1992; 3-6.5yrs) 16 3-6.5 2 2 0 2 3 Surgery Investigator Faces .74 
Tyler et al. (1992; 6.5-12yrs) 10 6.5-12 1 1 0 2 2 Surgery Investigator Faces .74 




                                            
4
 n refers to the sample reported for the correlation that was extracted from the primary study. If a specific n value was not reported for the extracted 
correlation, then it was assumed that the correlation was based on the whole study sample. 
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The random effects model reported in Figure 2 estimated a weighted average 
correlation of r = .52, 95% confidence interval (CI) [.39, .64]. This suggests a 
moderate positive correlation between self-report of pain and observation using the 
CHEOPS. The level of heterogeneity in the portions reported in the primary studies 
was found to be within acceptable parameters for the current review (tau2 = .04, 
Higgin’s I2 = 65.2%; Q = 23.00, p = .003).  
Figure 2: Forest plot illustrating the meta-analytic synthesis of correlations between 
pain ratings obtained by CHEOPS and self-report. TE = Measure of the effect, 
transformed into z score; seTE = measure of standard error; COR = r score. 
The quality effect model estimated a weighted average correlation of r = .54 
95% CI [.38, .66]. The quality effects model evidences a 2% increase relative to the 
random effects estimate. Accordingly, when the synthesis includes information about 
the methodological quality of the studies there is no substantive change in the 
estimation of the weighted average correlation.  
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As can be seen from Figure 3 the funnel plot shows asymmetry in the 
published studies. A trim and fill procedure imputed one additional result to adjust 
the symmetry of the funnel plot. The uncorrected estimate of the effect size was r 
= .52,   95% CI [.39, .64], the adjusted estimate was r = .50, 95% CI [.37, .62]. The 
adjusted point estimate suggests a lower effect than the original analysis. The 
Rosenthal algorithm suggests a failsafe number of 426 unpublished null effect 
studies required to reduce the meta-analytic effect of the nine results reported here 




Figure 3: Funnel plot illustrating trim and fill procedure for CHEOPS analysis. Black 
dots indicate primary studies, white dots indicate studies imputed by trim and fill 
procedure. 
To further explore the impact of uncontrolled covariates upon the correlation 
between self-report of pain and CHEOPS scores, a series of subgroup analyses 
were conducted. The first set of subgroup analyses exploring results according to 
quality rating found no significant differences in the synthesised r scores produced 
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by studies of low, moderate, or high quality or those that could not be rated, 
regardless of domain. The results of these subgroup analyses are presented in 
Table 7.  
Table 7: Subgroup analyses of primary studies reporting CHEOPS grouped by 
quality rating for each quality domain.  
The second set of subgroup analyses explored the influence of additional 
methodological variables. Although no difference was found when studies were 
analysed according to the source of pain described, a significant difference was 
found when studies were analysed according to the role of the person completing the 
CHEOPS, with researchers achieving significantly higher correlations to self-report 
than clinicians (p < .001). Table 8 presents the results of these analyses.  
 
 

































































Table 8: Subgroup analyses of primary studies reporting CHEOPS grouped by type 
of pain rated and role of person rating CHEOPS. 
Type of Pain 
Acute 
Procedural 
(k = 5) 
Post-Surgical 
(k = 4)  Q p 
 .49 .62  1.02 .313 
CHEOPS rater 
Clinician 
(k = 3) 
Researcher 
(k = 5) 
Not Stated 
(k = 1) 
  
 .25 .61 .47 18.32 < .001 
 
1.3.4.2. Visual Analogue Scale. 
The Visual Analogue Scale (VAS) is a commonly used assessment technique 
utilising a horizontal or vertical line with two anchor points on which the respondent 
marks along the line to indicate the level of pain they believe the child to be in. The 
distance from the bottom anchor point is then measured and reported as a score of 
pain. The VAS has been validated for use as a self-report scale in children six years 
and above (Von Bayer, 2006). Studies in the current review varied in the length of 
line used for a VAS, though 100mm was most typical, they also varied in the wording 
used for the two anchor points. 
The primary studies included in the analysis are reported in Table 9. There 
were 14 studies reporting a total of N = 1188 participants. The analysis included 
participants from the age of three to 18 years. The majority of studies in this analysis 
report using the same VAS for self-report as used for observer assessment (k = 9). 
Three studies reported multiple self-report scales to account for the needs of 
different age groups in their study, however individual correlations for these 
measures against the VAS were not given. 
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Table 9: Methodological details and quality rating of primary studies reporting a correlation between pain scores obtained from VAS 






















































Boivin et al. (2008) 239 4-12 2 1 1 1 2 Vaccination GP  FPSR / VAS .82 




Cohen et al. (2004) 39 8.8-11.1 1 3 1 1 2 Vaccination Nurse VAS .42 
Foster & Varni (2002) 50 8-12 2 1 2 1 3 Surgery Parent VAS .75 
Goodenough et al (1999) 110 3-15 1 2 3 1 3 Venipuncture Parent VAS / WBF .56 
Jensen (2012) 100 3-12 2 1 2 1 2 Dental extraction Parent WBF .79 
Jylli & Olsson (1995) 96 3-16 1 1 0 1 1 Painful procedures Parent 
Smiley 
scale / VAS 
.33 
Kelly et al. (2002) 78 8-15 1 1 2 3 3 
Painful conditions including 
trauma 
Parent VAS .63 
Knutsson et al. (2006) 100 3-9 0 1 3 1 3 Adenoidectomy Nurse  WBF .62 
Lamontagne et al. (1991) 13 8-18 0 1 3 1 3 Surgery Physician  VAS .59 
Singer et al. (2002) 63 4-7 1 1 3 1 2 







Tan & Stafford (1992) 73 5-16 0 2 1 1 1 Laser treatment Physician  VAS  .77 
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The random effects model reported in Figure 4 suggested a weighted average 
correlation of r = 0.62, 95% CI  [.51,  .70]. This suggests a moderate positive 
correlation between self-report of pain and observation using the VAS. An 
unacceptable level of heterogeneity in the portions reported in the primary studies 
was observed (tau2 = .07, Higgin’s I2 = 84.4%; Q = 83.54, p < .001). This suggests 
that the estimates of the primary studies are biased by the presence of uncontrolled 
or confounding factors. The quality effect model reported a synthesis of r = .60, 95% 
CI [.48, .69]. The quality effects model evidences an approximately 3.12% decrease 
relative to the random effects estimate. Accordingly, when the synthesis includes 
information about the methodological quality of the studies there is no substantive 







Figure 4: Forest plot illustrating the meta-analytic synthesis of correlations between 
pain ratings obtained by VAS and self-report. TE = Measure of the effect, 
transformed into z score; seTE = measure of standard error; COR = r score. 
None of the studies met the criterion for removal therefore no corrections 
were made to the analysis based on the leave one out analysis. Because of the high 
levels of heterogeneity identified within the synthesis, a funnel plot was not 
considered appropriate. 
The subgroup analyses for study quality found significant differences in the 
synthesised correlations when grouping by sample selection procedures, and when 
grouped according to their use of blinding, however, as seen in the results presented 
in Table 10, the direction of the effect is unclear across the groups. In the analysis of 
differences grouped by sample selection, the lowest correlation values were found in 
studies that were rated as low quality. When studies were grouped according to 
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blinding procedures the lowest correlations were found in the groups which were 
categorised as “unable to rate”, however, this category comprised of only one study, 
and no clear pattern can be seen between the differences in correlations found 
between low, moderate and high quality studies. 
Table 10: Subgroup analyses of primary studies reporting VAS grouped by quality 
rating for each quality domain. 
 
To further explore the impact of uncontrolled covariates upon the association 
between observer pain scores obtained using the VAS and self-report pain scores a 
series of subgroup analysis were conducted. As with the other meta-analyses, type 
of pain, and the identity of the observer were conducted as subgroup analyses. The 
VAS was the only measure included in the meta-analyses where there were studies 
in which the self-report and observer scale were the same alongside studies in which 
the self-report scale differed, allowing a sub-group analysis exploring the effects of 
using the same scale for observers and self-report. The analysis, presented in Table 











(k) Q p 








14.29 < .001 

















17.20 < .001 






















11, found no difference between studies comparing observational VAS to self-report 
VAS and those comparing observational VAS to different self-report measures. 
Table 11: Subgroup analyses of primary studies reporting CHEOPS grouped by type 





(k = 8) 
Post-Surgical 
(k = 3) 
Other  
(k = 3) Q p 
 .64 .66 .50 2.73 .256 
VAS rater 
Clinician  
(k = 8) 
Parent  
(k = 5) 
Not Stated 
(k = 1) 
  




(k = 6) 
Other  
(k = 5) 
VAS & 
Other  
(k = 3)  
 
 .62 .62 .61 0.00 .999 
 
1.3.4.3. Face, Legs, Activity, Crying and Consolability. 
The Face, Legs, Activity, Crying and Consolability (FLACC; Voepel-Lewis, 
Shayevitz & Malviya, 1997) rates the five behavioural domains forming the name of 
the measure, each on a 0 - 2 scale, to produce a score of pain intensity between 0 - 
10. It has been validated in the assessment of both brief procedural pain, and the 
pain experienced following surgical procedures. 
The primary studies included in the analysis are reported in Table 12. There 
were nine studies reporting a total of N = 730 participants. The analysis included 
participants from the age of three to 16 years. The study by Yeh (2005) reported 
correlations for multiple age groups, so each of these groups was included in the 
synthesis separately. The random effects model in Figure 5 was calculated using the 
generic inverse variance method. The random effects model suggested a weighted 
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average correlation of r = .65, 95% CI [.56, .73]. This suggests a moderate positive 
correlation between self-report of pain and observation using the FLACC.  
The level of heterogeneity in the portions reported in the primary studies was 
found to be within acceptable parameters for the current review (tau2 = .04, Higgin’s 
I2 = 69.6%; Q = 32.85, p < .001).  
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Table 12: Methodological details and quality rating of primary studies reporting a correlation between pain scores obtained from 














































Berberich & Landman (2009) 41 4-6 1 1 1 2 2 Vaccination Investigator FPSR .74 













Chadha et al. (2013) 69 3-12 1 2 3 2 2 Nasendoscopy Observer WBF .63 




Dentist WBF .39 
Emmott et al (2017) 112 3-6 1 2 1 2 1 Venipuncture Observer S-FPS .74 
Nilsson et al. (2008) 80 5-16 1 2 1 3 3 Cannulation Nurse CAS .61 
Risaw et al (2017) 210 4-6 0 1 1 3 2 Blood sampling Researcher WBF .79 
Yeh (2005; 3-4yrs) 32 3-4 1 1 0 2 3 Surgery Not named Oucher .59 
Yeh (2005; 5yrs) 35 5 1 1 0 2 3 Surgery Not named Oucher .75 




Figure 5: Forest plot illustrating the meta-analytic synthesis of correlations between 
pain ratings obtained by FLACC and self-report. TE = Measure of the effect, 
transformed into z score; seTE = measure of standard error; COR = r score. 
The quality effect model reported a synthesis of r = .63, 95%CI [.53, .71]. The 
quality effects model evidences an approximately 3.24% decrease relative to the 
random effects estimate. Accordingly, when the synthesis includes information about 
the methodological quality of the studies there is no important change in the 
synthesis of these study. 
As can be seen from Figure 6 the funnel plot shows asymmetry in the 
published studies. A trim and fill procedure was undertaken to adjust the symmetry 
of the funnel plot. The uncorrected estimate of the effect size is r = .68, the adjusted 
estimate is r = .71, 95% CI [.63, .78]. The adjusted point estimate suggests greater 
effect than the original analysis. The Rosenthal algorithm suggests a failsafe number 
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of 1532 unpublished null effect studies required to reduce the meta-analytic effect of 
the nine results reported here.   
Figure 6: Funnel plot illustrating trim and fill procedure for FLACC analysis. Black 





Subgroup analyses by quality rating, presented in Table 13, suggest a 
significant effect of sample selection, with slightly higher correlations reported from 
studies categorised as “unable to rate” than those categorised as “low quality” on the 
sample selection domain. However the effect of sample selection may be discounted 
based on the disproportionate spread of studies between groups. The additional 
subgroup analyses presented in Table 14 found no significant results based on the 
role of the person completing the FLACC, or type of pain being rated. 
Table 13: Subgroup analyses of primary studies reporting FLACC grouped by quality 















(k) Q p 







(0) 12.53 < .001 







(1) 7.78 .020 







(2) 0.67 .717 









(2) 0.74 .391 







(5) 5.69 .058 
 
Table 14: Subgroup analyses of primary studies reporting FLACC grouped by type of 





(k = 6) 
Post – 
Surgical  
(k = 4) 
Other  
(k = 1) Q p 




(k = 3) 
Researcher  
(k = 5) 
Not named 
(k = 3) 
  
 .52 .73 .61 8.44 .015 
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1.3.4.4. Observer Pain Scale. 
The Observer Pain Scale (OPS; Hannallah et al., 1987) scale was found 
reported under a range of names, including the Hannallah Pain Scale, the Broadman 
Pain Scale, and the Observer Pain and Distress Scale. The measure was originally 
reported in a 1987 study comparing the effectiveness of different nerve block 
techniques (Hannallah et al., 1987). However, an evaluation of the psychometrics of 
the OPS was not published until a year later (Broadman, Rice & Hannallah, 1988), 
hence both the 1987 and 1988 references are found reported in the literature, though 
both refer to the same scale. The original scale rates blood pressure and four 
observed behaviours, each on a 0 - 2 scale, to produce a total score of 0 - 10. Some 
studies choose to omit the blood pressure measurement and rely only on the four 
behaviours with a 0 - 8 total scale. 
Only one study was available which reported correlations between the OPS 
and self-report of pain. Bringuier et al (2009) is also described in the analysis for the 
CHEOPS and the FLACC. The study presents an investigation into the efficacy of 
behavioural pain tools and so utilized four different behavioural assessments 
alongside the FPSR as a self-report measure. The study reported using the OPS 
without the item relating to blood pressure. Although the original sample reported by 
Bringuier et al. (2009) is  N = 150, the correlation reported for the time point which is 
closest to the painful procedure is based on n = 19. The reported correlation 





1.3.4.5. Wong Baker Faces. 
Although multiple versions of the faces pain scale were reported, the Wong-
Baker Faces Scale (WBF; Wong & Baker, 1988) was the most frequently used. The 
WBF was originally published as a self-report scale for children. A series of six 
cartoon faces ranging from smiling to crying are depicted with verbal anchors 
ranging from “No pain” to “Hurts worst”. Each face corresponds to a numerical score, 
increasing in twos, from 0 - 10. The majority of studies included in this review that 
used a WBF reported it as a self-report scale as well as obtaining ratings on the 
WBF from observers. 
The primary studies included in the analysis are reported in Table 15. There 
were four studies reporting a total of N = 369 participants. The analysis included 
participants from the age of three to  15 years. 
The random effects model in Figure 7 was calculated using the generic 
inverse variance method. The random effects model suggested a weighted average 
correlation of r = .86 and a 95% CI [.51, .97]. This suggests a moderate positive 




Table 15: Methodological details and quality rating of primary studies reporting a correlation between pain scores obtained from 















































Chadha et al. (2013) 69 3-12 
1 1 1 1 2 
Nasendoscopy Parent WBF .68 
Moadad et al. (2015) 48 4-12 
2 1 1 1 3 
IV insertion Nurse WBF .37 
Mohan et al.  (2015) 42 10-15 
1 1 1 1 2 "painful 
procedures"  
Nurse WBF .98 
Risaw et al (2017) 210 4-6 
0 1 1 1 2 Blood 
sampling 





Figure 7: Forest plot illustrating the meta-analytic synthesis of correlations between 
pain ratings obtained by WBF and self-report. TE = Measure of the effect, 
transformed into Fisher’s z score; seTE = measure of standard error; COR = r score. 
 
An unacceptable level of heterogeneity in the portions reported in the primary 
studies was observed (tau2 = .56, Higgin’s I2 = 97.6%; Q = 123.83, p < 0.0001). This 
suggests that the estimates of the primary studies are biased by the presence of 
uncontrolled or confounding factors. The quality effect model reported a synthesis of 
r = 0.84, 95% CI [.43, .96]. The quality effects model evidences an approximately 
2.92% decrease relative to the random effects estimate. 
Despite excessive levels of heterogeneity being identified, none of the studies 
met the criterion for removal therefore no corrections were made to the analysis 
based on the leave one out analysis. Because of the high levels of heterogeneity 
identified and the small number of primary studies available for the synthesis of the 
WBF, the funnel plot and sub-group analyses were not conducted as results would 
not have been meaningful. 
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1.3.4.6. Comparison between observational measures. 
The results of the conducted meta-analyses are summarised in Table 16. 
Moderate to strong associations with self-report scores were identified for all 
observational assessments. Unacceptable levels of heterogeneity were identified in 
two of the analyses (VAS, I2 = 85.8%; WBF, I2 = 97.6%). Highest correlations 
between observer ratings and self-report were identified for the WBF scale. 
Table 16: Results of meta-analytic syntheses of correlations between pain scores 
obtained from observer tools and those obtained from self-report, compared across 











Tau2 I2 Q p 
CHEOPS 8 517 4-15 
.52 
[.39, .64] 
.04 65.2% 23.00 .003 
VAS 14 1188 3-18 
.62 
[.51, .70] 
.07 84.4% 83.54 < .001 
FLACC 9 730 3-16 
.65 
[.55, 0.73] 
.04 69.6% 32.85 < .001 
OPS 1 19 4-7 .64 - - - - 
WBF 4 369 3-15 
.86 
[.51, .97] 








The current review aimed to identify the observational tools utilised in the 
published literature to assess pain in children. A total of 62 unique observational 
assessments were found reported across 526 papers published from 1979-2018. 
The second aim of the current study was to evaluate the evidence of validity for 
commonly used measures of pain by synthesising the available data regarding 
correlation to self-report, the current gold-standard in pain assessment. The five 
most commonly reported observational assessments of pain were found to have 
moderate to strong positive correlations to self-report, though the availability of these 
data varied considerably between measures. The current review is the first to apply 
meta-analytic methods to assess the validity of current pain assessment methods in 
research using child participants. This meta-analysis is strengthened by the 
comprehensive search, and assessment of the five most commonly used measures. 
Given that nearly two thirds of the identified literature reported using at least one of 
the five most common measures (65.78%), the current review has far reaching 
implications for research and practice.  
A total of 62 tools were identified across the 526 papers reviewed; Anderson 
et al. (2017) identified 65 measures using broadly similar inclusion criteria for their 
literature review. The slight difference in the number of identified measures may be 
due to differences in the categorisation of techniques such as global rating scales, or 
measures that were designed for the needs of one specific study. Both Anderson et 
al., and Von Baeyer and Spagrud (2007) highlight a lack of published evidence 
regarding the psychometric properties of the observational measures used to assess 
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pain in children. The sheer number of measures identified is a concern in this regard; 
such a range of measures introduces heterogeneity and confusion to the literature 
and makes it difficult to compare findings across studies. This is particularly the case 
for the 29 measures that were reported at very low frequency (k = 1) in the current 
review. The limited use of some of the reported measures is easily explained 
because of the exclusion criteria of the current review, for example the Comfort scale 
(Ambuel, Hamlett, Marx & Blumer, 1992) was reported in only four studies, but is 
designed for use in very young infants, and is reported much more frequently in 
studies assessing pain in infants under 12 months (Duhn & Medves, 2004). Similarly, 
the Echelle Douleur Enfant San Salvador (Collignon & Giusiano, 2001), was reported 
in only one study, but is designed to assess pain in children with cerebral palsy, a 
group which was excluded from the current review. However, this explanation does 
not apply to all of the measures reported at low frequency, and 13 papers were 
identified in which authors created their own measure for the purposes of the study, 
rather than using already established and validated measures. In these cases it is 
difficult to justify the use measures that have little record of publication and therefore 
lack robust evidence of validity or reliability. Unless there is clear justification for why 
published measures fail to meet the needs of the study, researchers should avoid 
adding to this already crowded picture.  
The second aim of the review was to evaluate the convergence between self-
report and the scores obtained from the five most commonly used observational 
measures of pain. The five measures identified as being most commonly reported in 
the literature were the Children’s Hospital East Ontario Pain Scale (CHEOPS; 
McGrath et al., 1985) which was used in 121 studies, the Visual Analogue Scale 
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(VAS) which was used in 87 studies, the Face, Legs, Activity, Crying and 
Consolability (FLACC; Voepel-Lewis, Shayevitz & Malviya, 1997) which was used in 
81 studies, the Observer Pain Scale (OPS; Hannallah et al., 1987) which was used 
in 71 studies, and the Wong-Baker Faces Scale (WBF; Wong & Baker, 1988) which 
was used in 26 studies. Based on the categories of measures provided by Von 
Baeyer & Spagrud (2007), the CHEOPS, FLACC, and OPS, fit the description of 
behavioural rating scales or behavioural checklists, whereas the VAS and WBF are 
both considered global rating scales.  
1.5.1. Children’s Hospital East Ontario Pain Scale 
The CHEOPS was the most commonly reported observational measure and 
the synthesis of correlations revealed a moderate positive correlation with self-report 
measures across the eight available primary studies (r = .52). Subgroup analyses 
revealed an effect of rater, suggesting that CHEOPS ratings were more closely 
associated with self-report of pain when the observer using the CHEOPS was a 
researcher rather than a clinician. It may be that researchers are more likely to 
comply rigidly to the definitions given by a measure, whereas clinicians may have 
more of a tendency to alter their ratings based upon clinical experience. This finding 
must be treated with caution however, not only because of the small number of 
studies included in the analysis, but also because of the lack of clarity between the 
categories of rater. Raters were classified as “researcher” when the study described 
them as researchers or observers as opposed to using a clinical job title, however 
this does not exclude the possibility that raters included in the researcher category 
may also have been clinically trained. If further data support the finding that 
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researchers provide CHEOPS ratings which are closer to self-report than ratings 
provided by clinicians, then studies seeking to use the CHEOPS as a proxy for self-
report may be better placed to use researchers to provide such ratings, or to give 
explicit instruction or training to others using the measure. 
A review by the Pediatric Initiative on Methods, Measurement, and Pain 
Assessment in Clinical Trials (PedIMMPACT) group regarding the use of 
observational measures of pain recommends the use of the CHEOPS for clinical 
trials, but only for the assessment of acute pain (Von Baeyer & Spagrud, 2007). The 
current review would support the recommendations of the PedIMMPACT group and 
suggests that published research is broadly in line with best practice, in that the 
CHEOPS was identified as the most commonly used measure. It should be noted 
however that contrary to PedIMMPACT recommendations, almost half of the primary 
studies in the CHEOPS synthesis used the measure to asses post-surgical pain, 
practice which is not supported by PedIMMPACT recommendations. The current 
review attempted to assess if the association between observed pain scores on the 
CHEOPS and self-reported pain was poorer in studies assessing post-surgical pain, 
using sub-group analysis methods. No significant difference was found in the 
correlation with self-report between those studies assessing procedural pain and 
those assessing post-surgical pain, which does not appear to support the caution 
expressed by PedIMMPACT. It is also of note that although the weighted correlation 
calculated between the CHEOPS and self-report was of moderate strength, it was 
the weakest of the five measures assessed.  
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Although it is promising that the CHEOPS was the most frequently identified 
measure, and that the meta-analysis suggests a moderate positive correlation to 
self-report, further data are needed to assess whether the validity and reliability of 
the CHEOPS is still acceptable when the measure is applied to post-surgical pain. 
1.5.2. Visual Analogue Scale 
The VAS was the second most commonly reported observational measure. 
Unlike the CHEOPS, the VAS is a global rating scale, which does not use specific 
behavioural indicators to guide or justify ratings. The VAS was found to have a 
moderate positive correlation to self-report (r = .62), however this was only slightly 
stronger than the correlation calculated for the CHEOPS, which was the weakest 
correlation of the five. One strength of the VAS is that it can also be used as a self-
report scale; there is evidence that children as young as 6 years can reliably self-
report using the VAS (Von Baeyer, 2006). It was thought that the use of the same 
scale for self-report and observer report might be one factor explaining the 
correlation between the VAS and self-report. A sub-group analysis found that there 
was no difference in correlation found between studies that used the VAS for self-
report and those that used a different self-report scale. However, it is also arguable 
that almost all of the self-report scales used in the primary studies reported here are 
simply variations of a VAS, the differences being in the choice of anchor points and 
the use of visual aids, such as pictures of faces, to aid rating choice.  
Unlike the behavioural rating scales, no effect of rater was found for the VAS. 
The sub group analysis of rater for the VAS included clinicians, researchers, and 
parents assessing pain in their own children, suggesting the VAS performs 
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consistently regardless of the clinical knowledge of the person using it, or their 
knowledge of the child being rated. Although overall observer ratings obtained from 
the VAS correlated well with self-report, there was a wide range of correlations 
reported across the primary studies included (r = .18 - .82), and unacceptably high 
levels of heterogeneity between studies. The high levels of heterogeneity identified in 
the primary studies limit the conclusions that might be drawn from this meta-analysis. 
High levels of heterogeneity suggest that the findings of the studies cannot be 
reliably attributed to idiosyncratic variation in the correlation, but are more likely 
related to methodological factors. The leave one out analysis failed to identify a 
single study that made a significant contribution to the heterogeneity, and sub-group 
analyses of study quality also failed to return significant findings. With no clear 
source of heterogeneity identified in the current review, it is difficult to draw any 
robust conclusions from the synthesis of studies using the VAS. 
1.5.3. Face Legs Activity Crying Consolability 
The FLACC was identified as the third most frequently used measure in the 
current review. The FLACC was found to have a moderate-strong positive correlation 
to ratings of pain obtained by self-report. The weighted correlation found for the 
FLACC was higher than that found for either of the other behavioural scales (the 
CHEOPS and OPS) explored in the current review, though it performed slightly 
poorer than the WBF.  
Unlike the CHEOPS, PedIMMPACT recommends the use of the FLACC for 
the assessment of both acute procedural and post-surgical pain in clinical trials. The 
FLACC also contains fewer items and appears to be a simpler tool to administer than 
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the CHEOPS. Given that the FLACC can be applied to a broader range of settings 
and appears to perform better than the CHEOPS regarding association with self-
report, it begs the question why the CHEOPS is used more frequently. The finding 
that the CHEOPS is used more frequently than the FLACC may be explained by the 
breadth of the current review with regards to year of publication. The CHEOPS was 
first published in 1985, a full 12 years before the FLACC. This is reflected in the 
publication year of the primary studies, the primary studies included in the meta-
analysis of the CHEOPS were all published between 1992 and 2011. In contrast, the 
primary studies included in the meta-analysis of the FLACC were more recent, all 
having been published since 2005. It may be that modern researchers are indeed 
showing a preference for the FLACC but this has not yet been sufficient to overtake 
the CHEOPS due to the historical primacy of the CHEOPS. The results of this meta-
analysis would support the use of the FLACC where an observational assessment of 
pain is required, given the positive correlation between the FLACC and self-report, 
the simplicity of the measure, and the variety of settings for which it has been 
validated. 
1.5.4. Observer Pain Scale 
Despite being widely used in the reviewed literature, the OPS was rarely 
compared to self-report. Only 11.27% of studies using the OPS included a measure 
of self-report (k = 8), and in only one of those was an analysis of the association 
between the two measures reported.  
The first aim of the current review was to identify the observational measures 
used to assess pain in children in the literature, however this seemingly simple task 
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was complicated in some cases by multiple measures being referred to by similar 
names, or by a single measure being referred to by multiple names. The OPS was 
one of the most prolific examples of this. The OPS was found referred to as the 
Observer Pain Scale, the Hannallah Pain Scale, the Broadman Pain Scale, and the 
Observer Pain and Distress Scale. There were also variations found in scoring and 
administration, most commonly the omission of the item regarding blood pressure, 
however the scoring variations appeared to bear no relation to the different names. 
Inconsistent reporting of measures in research increases the challenges when 
attempting to synthesise the literature.  
Although a meta-analysis of the literature could not be conducted for the OPS, 
the correlation between the OPS and self-report found by Bringuier et al. (2009) was 
in line with the correlations found between other scales and self-report (r = .52 - .86). 
The findings of the current review suggest that the OPS compares well with other 
observational measures of pain in relation to its correlation to self-report, however 
the correlation is based on a very small sample and so must be interpreted with 
caution. 
1.5.5. Wong Baker Faces 
The WBF was the least used of the five measures reviewed. The synthesis of 
the four available studies meeting inclusion criteria suggest that the WBF, when 
used as an observer scale, achieves the highest correlation to self-report (r = .86) 
across the five tools reviewed. However, the synthesis of the WBF was also the 
synthesis with the most heterogeneity. Similar to the VAS, the four studies included 
reported a wide range of correlations, and no clear sources of heterogeneity could 
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be identified. Because of the small number of primary studies, sub-group analyses 
were not conducted. All of the primary studies reporting the WBF as an observational 
measure also used the WBF for collection of self-report. Because no studies were 
identified that used the WBF as an observational measure with a different self-report 
tool, the effect of using the same tool for observation and self-report could not be 
assessed in the case of the WBF. Despite finding a strong positive correlation to self-
report, the current review concludes that the current literature regarding the WBF is 
too variable to support a recommendation for the use of the measure as a proxy for 
self-report in clinical or research practice. 
1.6. Limitations 
The current review extends current understanding of the validity of commonly 
used observational assessments of pain by exploring the association between 
scores obtained from observation and those obtained by self-report, which is 
considered the gold-standard. Correlation to self-report offers some insight to validity, 
however there are limitations to the degree of variability that may be detected using 
correlation analysis, and the approach is reliant on the assumption that self-report of 
pain is an accurate measure of pain intensity. Despite being considered the gold-
standard, self-report as a measure of pain has limitations, particularly when applied 
to children. Firstly one must be careful to ensure that children can understand and 
engage in the self-report tool used. In the current review, steps were taken to ensure 
the validity of self-report, for example, by the exclusion of studies with children under 
three years of age, who are unlikely to be reliable in their reporting of pain. Use of 
self-report, in particular the application of a self-report tool that had been validated 
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for use in the named sample, was also a domain in the quality rating criteria. 
However, many of the primary studies received low ratings in this quality domain. 
Even if self-report provided a perfect measure of pain intensity, correlation provides 
only limited insight into the differences in intensity ratings between observation and 
self-report. For example, even where significant correlations have been reported 
between child and parent scores on the VAS, agreement between pain ratings has 
been found to be poor (Kelly, Powell & Williams, 2002). So long as children are 
ranked in appropriate order with regard to which children appear to experience the 
most pain, a correlation analysis will not detect disagreements in the rating of pain 
intensity between the child and observer.  
Correlation is not the only available method to assess relationships between 
two measures, however it was the most widely reported. Some of the papers that 
utilised observation measures alongside self-report did conduct comparisons by 
defining thresholds for scores to group participants into those experiencing no pain, 
or moderate-severe pain. However, the variations in methodology and reporting 
between such studies would have made a meta-analytic synthesis of the data very 
difficult. Correlation became the clear option for the current review because of the 
availability of data and because of the relative consistency in the reporting of 
correlations. Unfortunately some papers were excluded from the meta-analysis 
because, although they reported conducting a correlation analysis, they failed to 
report an r value. Some studies without an r value were those reporting no significant 
correlation between observer and self-report, which may suggest publication bias 
within the literature. However, it was also the case that r values had to be calculated 
for two studies who reported a p value without reporting an r value (Hee et al., 2003; 
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Benini et al., 2004). In both cases the calculated r value was considerably lower than 
other r values included in the synthesis, this may be a product of the transformation 
calculation; however it may also suggest why the authors chose to omit the r value in 
their reporting, instead opting to simply report the value as being significant. The 
synthesis reported here was the most comprehensive possible without conducting 
significant transformations of the published data. Future studies must ensure that 
data is reported in full, including non-significant findings, although it will not negate 
the problem of publication bias, it will allow for future reviews to be more 
representative of the full depth of knowledge available on these measures which are 
potentially so important in the development of better medical techniques. 
1.7. Conclusions 
The current review was conducted to explore the use of observational 
assessments to assess pain in children in research literature. A total of 62 measures 
were identified, suggesting a great deal of inconsistency in current practice regarding 
the assessment of pain in children participating in clinical studies.  
Two of the five most frequently used observational measures, the VAS and 
WBF, can be categorised as global rating scales. The results reported here suggest 
that global rating scales may have a higher correlation to self-report but also present 
unacceptably high levels of heterogeneity, limiting the usefulness of the analysis. It 
may be that heterogeneity is unavoidable when using global rating scales due to the 
lack of guidance regarding scoring criteria, potentially increasing the influence of 
individual factors such as user experience or bias. The FLACC, a behavioural 
checklist, was found to have a weighted correlation higher than the VAS, and 
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heterogeneity in the literature was found to be lower than in the case of either the 
VAS or WBF.  
The results of the current study support the use of observational scales by 
providing evidence of a positive association to self-report, however the variability 
found within the literature was of concern. Recommendations for future research 
would be to restrict the use of observational measures of pain to those measures 
that are already well established in the literature, and to provide further exploration 
and evidence of the use of global rating scales as observer measures, as this study 
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CHAPTER TWO, EMPIRICAL PAPER:  
DEVELOPING A SCREENING TOOL TO DETECT GASTRIC PAIN IN CHILDREN 





Background: Gastro-oesophageal Reflux Disease (GORD) is a painful treatable 
health condition with an increased prevalence in people with Intellectual Disabilities 
(ID). GORD may be underdiagnosed in people with ID due to difficulties in self-
reporting of pain, which is a primary symptom, and the invasive procedures required 
to confirm diagnosis. The Gastric Distress Questionnaire (GDQ) is a parent report 
questionnaire designed to screen for GORD in people who cannot self-report. The 
studies reported here offer an exploration of the features and validity of the GDQ and 
attempt to develop an accompanying brief observational tool. 
Method: GDQ scores were compared to parent report of recent GORD for 599 
children aged 1-18 with ID with and without a known underlying genetic syndrome 
and autism. Behavioural coding was conducted of footage of 49 children with ID. 
Observers coded behaviours from the GDQ which could be seen in brief observation 
periods. 
Results: A five factor structure was established for the GDQ. Significant differences 
were found in four of the factor scores and the GDQ total between children with and 
without recent GORD. No significant relationship was found between behaviours 
recorded by naïve observers and GDQ scores provided by parents. 
Conclusion: The GDQ may be a useful tool for detecting children who could benefit 
from medical investigation of GORD. Further study is required comparing GDQ 
scores to the outcomes of medical diagnostic procedures to establish construct 
validity. Furthermore, the findings reported here highlight the importance of parent 




In 2006 the United Nations published their convention on the rights of people 
with disabilities (CRPD), stating that all people should have “the right to the 
enjoyment of the highest attainable standard of health without discrimination on the 
basis of disability” (United Nations General Assembly, 2006). The UN CRPD was 
written not only to protect the rights of people with physical disabilities, but also those 
with intellectual disabilities (ID) of whom there are approximately 1.4 million living in 
the UK (Mencap, n.d.). The recent ‘Long Term Plan’ of the NHS outlines their 
commitment to tackle health inequalities, including providing the “right care” for 
children with ID (National Health Service, 2018). The inclusion of this pledge 
highlights the current limitations of UK health service provision for people with ID. 
These legislative and policy papers demonstrate the ongoing need to eliminate 
healthcare inequalities for people with ID. 
Health inequalities exist in many forms and have a far-reaching impact on the 
lives of people with ID. People with ID often already face vulnerabilities, in some 
cases due to pathologies associated with the genetic syndromes which underlie 
some IDs. Emerson and Baines (2011) also highlight deficiencies in healthcare 
provision as playing a key role in the differences in physical health outcomes for 
people with ID when compared to the typically developing population. The life 
expectancy of a person with ID is 19.7 years lower than that of a typically developing 
individual (Glover, Williams, Heslop, Oyinlola & Grey, 2017). A relationship has been 
demonstrated between severity of ID and mortality rates, with people with profound 
or multiple ID having a life expectancy 20 years lower than that of someone with mild 
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ID (Heslop, Blair, Fleming, Hoghton, Marriott & Russ, 2013). Research has identified 
a range of specific health problems that occur more frequently in people with ID, 
including epilepsy, sensory impairments, digestive problems, reflux, respiratory 
disease, poor oral health, and periodontal disease (Anders & Davis, 2010; Emerson 
& Baines, 2011). Critically, 98% of people with ID who die prematurely have one or 
more known long term medical condition at the time of their death; 20% have seven 
or more known medical conditions (Heslop, Blair, Fleming, Hoghton, Marriott & Russ, 
2013). Despite these and other data demonstrating the poor physical health 
outcomes associated with ID, people with ID often face barriers to recognition, 
diagnosis and treatment of health problems (Morin, Mérineau-Côté, Ouellette-Kuntz, 
Tassé & Kerr, 2012). Problems in communication are cited as one of the key barriers 
to treatment, with 70% of GPs reporting that they do not know how seriously to take 
health complaints made by people with ID (Lennox, Diggens & Ugoni, 1997). Other 
studies report a lack of training, appropriate assessment tools and clinician 
confidence as obstacles to improving outcomes (Malviya, Voepel-Lewis, Merkel & 
Tait, 2005; Lewis Gaffney & Wilson, 2017). As such, these studies demonstrate that 
a reduction in health inequality for people with ID is predicated on substantive 
changes to current practice, including better training and more specific tools to 
support clinicians working with this population. 
Many of the health problems that are common in people with ID are known to 
cause physical pain. In typically developing populations, self-report of frequency, 
intensity, or location of pain is the gold-standard of measurement, even in children as 
young as three years old (Stinson, Kavanagh, Yamada, Gill & Stevens, 2006). 
However, many people with ID are unable to self-report. For example, 52% of people 
85 
 
with ID who died prematurely had limited or no verbal communication (Heslop et al., 
2013). Even in individuals with ID who are verbal, many struggle to effectively 
describe the nature and location of their pain (Findlay, Williams & Scior, 2014). 
Failing to detect pain in people with ID can have significant consequences in addition 
to failing to treat potentially treatable health conditions. Physical pain is strongly 
associated with behaviours that challenge and poor sleep (Carr & Owen-DeSchryver, 
2007; Wiggs & Stores, 1996). The presence of behaviours that challenge increases 
the likelihood of reactive and restrictive behaviour management strategies, such as 
restraint or seclusion (Allen, Lowe, Brophy & Moore, 2009), and reduces quality of 
life (Beadle-Brown, Murphy & DiTerlizzi, 2009). The comorbidities associated with 
pain that have been demonstrated in people with ID provide further rationale for the 
investment in effective identification of pain and painful health conditions in this 
population. 
There are tools available which can reliably identify pain in people who cannot 
self-report, the meta-analysed data in chapter one demonstrates that observational 
measures of pain correlate well to self-reported pain scores.  Tools such as the Face 
Legs Activity Crying Consobility scale (FLACC; Merkel, Voepel-Lewis, Shayevitz & 
Malviya, 1997) and Non-Communicating Child Pain Checklist (NCCPC; Breau et al, 
2000) rely on observations of pain related behaviour from a care-giver or clinician 
and have shown good validity and reliability in measuring pain in people with ID 
(Crosta, Ward, Walkers & Peter, 2014). Although detection of pain in people with ID 
is an important step towards improving physical health outcomes, there is still a 
significant difference between recognising that someone is in pain and being able to 
accurately identify and treat the underlying causes. Measures that focus on 
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identification of specific painful health conditions may offer clinical utility in aiding 
diagnosis and therefore increasing the likelihood of treatment. One health condition 
which may benefit from the development of such a measure is Gastro-oesophageal 
Reflux Disease (GORD). GORD occurs when stomach acid repeatedly returns to the 
oesophagus, resulting in pain to the throat and chest. GORD is easily treated in the 
majority of cases; however, left untreated it can result in permanent damage to the 
cells which line the oesophagus, a condition known as Barrett’s oesophagus. 
Research suggests that people with Barrett’s oesophagus may be up to ten times 
more likely to develop oesophageal cancer (Solaymani-Dodaran, Logan, West, Card 
& Coupland, 2004). People with ID are at disproportionately high risk of experiencing 
GORD, with some studies suggesting a prevalence in this population as high as 50% 
(Bohmer et al., 2000; Haveman, Heller, Lee, Maaskant, Shooshtari & Strydom, 2010). 
When GORD is present, people with ID have significantly higher rates of self-
injurious behaviours and sleep problems (Luzzani, Macchini, Valade, Milani & 
Selicorni, 2003). However, GORD is also likely under-diagnosed in people with ID, 
because initial identification of the disease is typically based upon self-report of 
epigastric pain or heartburn (Hassal, 2001). Further challenges to successful 
treatment of GORD are conferred by the diagnostic assessment process; if GORD is 
suspected then painful and invasive procedures such as endoscopy are used to 
confirm the diagnosis (NICE, 2015) which clinicians may be hesitant to perform 
without significant justification of need. As such, NICE guidelines have cited the 
identification of behavioural markers of GORD as a current research priority (NICE, 
2015). Thus, the development of a behavioural screening tool to aid identification of 
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this common and under-recognised painful health condition in people with ID could 
have significant impact on unequal health outcomes. 
In summary, health inequalities are well evidenced as affecting the duration 
and quality of life of people with ID. In particular, pain is common and can have a 
significant impact of behaviour and quality of life, but is hard to recognise due to the 
communication impairments that are prevalent in this population. There are particular 
health problems which affect people with ID disproportionately in comparison to the 
typically developing population, and improving recognition and diagnosis of such 
health problems may be one step towards tackling the broader issue of health 
inequality. GORD is a health problem which is more common is people with ID, and 
is of particular interest because it is painful and can have long term consequences if 
left untreated, but is frequently easily treatable if diagnosed.  
Therefore, the current study investigates a tool which shows promise in the 
identification of gastric pain and GORD symptoms in people who cannot verbally 
report their internal experiences. The Gastric Distress Questionnaire (GDQ) is a 
caregiver report questionnaire which asks about the frequency of observable 
behaviours related to GORD (Oliver & Wilkie, 2005). There has been limited 
exploration of the psychometric properties of the GDQ. Clinical utility of the GDQ 
would be improved if the factors underlying the measure were understood, and if a 
cut-off was established that could identify children who may benefit from further 
investigation for GORD symptoms. The most robust method to study the validity of a 
measure of GORD would be to compare the measure against gold-standard clinical 
diagnostic procedures. However, medical diagnosis typically involves painful 
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invasive procedures such as endoscopy, which would pose significant ethical 
considerations. Most children with ID have continuous support from either a parent 
or other caregiver who would be well placed to reliably report on both recent 
behaviours and any current or previous diagnosis of GORD. Although the GDQ is 
not an age specific measure, focusing an initial investigation on children provides an 
opportunity to explore the relationship between scores on the GDQ and diagnosis of 
GORD, using the knowledge of caregivers, avoiding the need for invasive medical 
procedures. If a relationship is found between GDQ scores and parent/caregiver 
report of GORD then this would offer support for the clinical utility of the measure 
and provide justification to conduct further investigation utilising medical confirmation 
of diagnosis. 
A second opportunity is to examine the utility of the behavioural indicators in 
the GDQ as a brief observational screening tool for naïve observers or clinicians. 
The GDQ is reliant on caregiver report; however, not everyone with ID has access to 
someone who could reliably report on their behaviours. Additionally, studies have 
indicated that clinicians often express uncertainty regarding the accuracy of 
caregiver reports in medical settings (Lewis, Gaffney & Wilson, 2017). Given that 
many clinicians feel ill equipped to assess pain and physical health people with ID 
themselves, development of an appropriate tool to support clinical judgement may 
help address this barrier. One investigation suggests that as many as one in five 
problems in diagnosis were directly related to issues in accessing specialist care, 
including referrals not being made (Heslop, Blair, Fleming, Hoghton, Marriott & Russ, 
2013). Providing a screening tool for primary care settings which could help to 
identify those people that would benefit from referral to specialist services, would 
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help to ensure that more people with ID could receive appropriate diagnosis and 
treatment.  
In conclusion, the studies reported here address two broad aims: 
1. To provide a preliminary investigation of the structure, sensitivity, and 
specificity of the GDQ 
2. To explore the potential feasibility of converting the GDQ into a brief 
observational screening tool for use by naïve observers in primary care 
settings. 
2.3. Study one 
Study one aims to provide a preliminary investigation of the psychometric 
properties of the GDQ by addressing the following aims: 
1. To explore the underlying factor structure of the GDQ 
2. To explore to what extent GDQ scores distinguish children with GORD from 
those without GORD, according to parent/caregiver reports of GORD 
diagnosis 
3. To identify a clinical cut-off score for the GDQ which would provide adequate 
sensitivity and specificity for use as a screening tool in primary care settings 
4. To explore whether GDQ scores relate specifically to symptoms of GORD 






This study utilised data collected from previous studies carried out by the 
Cerebra Centre for Neurodevelopmental Disorders. In order to collect a 
heterogenous and representative sample of children with ID, data were taken from 
studies investigating multiple different genetic syndromes associated with ID as well 
as children with ID without a known genetic syndrome, and children with autism. In 
all of the included studies the GDQ, the Wessex, and a background health 
questionnaire were included in the protocol and completed at the same time by 
parents/caregivers of children with ID. Recruitment was conducted through 
syndrome specific charities, parent support groups, and schools, residential, and day 
services. More specific information regarding recruitment is available from Richards, 
Oliver, Nelson and Moss (2012), Arron, Oliver, Moss, Berg and Burbidge (2011), and 
Oliver, Berg, Moss, Arron and Burbidge (2011). 
2.3.1.1. Measures. 
Gastric Distress Questionnaire (GDQ; Oliver & Wilkie, 2005) The GDQ is an 
informant report measure comprising 17 items reporting on behaviours observed in 
the previous two weeks. The majority of the behaviours are scored on a five point 
likert scale relating to the frequency with which the behaviour has been observed, 
from “not occurred” to “occurs more than once an hour”. 
Health Questionnaire: (Hall, Arron, Sloneem & Oliver, 2008) The health 
questionnaire is a background questionnaire used to collect information regarding 
health problems that the child has been diagnosed with and/or treated for both 
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historically and recently. For the purposes of the current study, data regarding the 
severity of health problems reported in the last month were utilised. 
The Wessex: (Kushlick, Blunden & Cox, 1973) The Wessex assesses 
physical and social abilities via caregiver report. It scores across five domains; 
continence, mobility, self-help skills, speech, and literacy. Kushlick, Blunden & Cox 
(1973) report that the scale has good inter-rater reliability for both children and adults 
with ID.  
2.3.1.2. Sample. 
The databases of several studies which included the GDQ and Health 
Questionnaire were included. To be included in the analysis participants were 
required to meet the following inclusion criteria: 
1. Older than one year of age 
2. Not older than 18 years of age 
3. Complete data for all items on the GDQ 
4. Valid response to the question “Has your child experienced gastric reflux in 
the last month?” from the Health Questionnaire 
Due to the inclusion of multiple studies, nine cases of duplicate data were 
identified. In these cases, only the earliest valid data set collected for each individual 
was included in the analysis. Before any further analysis was conducted, the GDQ 
total was checked for outlying scores using visual inspection of a basic box and 
whisker plot. Two participants with outlying scores were removed. 
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Table 17 displays the details of the final sample. After removal of participants 
who did not meet inclusion criteria, duplicates, and outliers, the final sample was N = 
599 with a mean age of 9.37 (range 1 - 18) years. A total of 13 known genetic 
syndromes were included in the study, as well as children with a primary diagnosis of 
autism and children with a primary diagnosis of ID with no known cause. For the 
majority of the sample (n = 560) there were also data available from the Wessex 
(Kushlick, Blunden & Cox, 1973) relating to functional behaviours and sensory 
impairments which is outlined in Table 17. 
2.3.1.3. Analysis. 
The primary outcome measure was GDQ total scored as a sum of the likert 
values of all 17 items. This was assessed against the parental report of gastric reflux 
in the previous month. Data on reflux from the Health Questionnaire were collected 
according to severity – none, mild, moderate or severe, however the numbers for 
each severity group were small, so to maximize sample size and power, the groups 
were condensed into a binary outcome (no reported reflux/ reported reflux), in which 
‘reported reflux’ included all levels of severity.  A Shapiro-Wilk analysis on the GDQ 
total was significant, indicating skewness within the sample, therefore non-
parametric analyses were used throughout. 
The first aim of the present study was to establish the underlying structure of 
the GDQ and examine the existence of any factors. Principal components analysis 
(PCA) with varimax rotation was utilised, in accordance with other studies reporting 
exploratory factor analysis of pain measures (Hermann, Zohsel, Hohmeister & Flor, 
2008; von Baeyer, Chambers & Eakins, 2011). Consistent with previous studies, 
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factors with eigenvalues > 1 were retained, and item loading was determined based 
on the selection of items with loading values > .4 in the varimax rotation (Field, 2005).  
Table 17: Age, sex, diagnosis, functional behaviour, and sensory impairments 
relating to the sample of study one (N = 599). 
  n % of sample 
Age group   
1-3 years 52 8.68 
4-7 years 169 28.21 
8-11 years 179 29.88 
12-15 years 137 22.87 
16-18 years 62 10.35 
Sex   
Male 424 70.80 
Female 175 29.20 
Diagnosis   
Angleman Syndrome 13 2.17 
Cri du Chat Syndrome 24 4.01 
Cornelia de Lange Syndrome 32 5.34 
Fragile X Syndrome 65 10.85 
Prader Willi Syndrome 60 10.02 
Lowe Syndrome 23 3.84 
Smith Magenis Syndrome 8 1.34 
Soto Syndrome 22 3.67 
Tuberous Sclerosis Complex 45 7.51 
Phelan McDermid Syndrome 29 4.84 
1p36 18 3.01 
9q34 11 1.84 
8p23 15 2.50 
Autism 222 37.06 
ID no known cause 12 2.00 
Sensory impairments   
Poor hearing/deaf (n=558) 39 6.50 
Poor vision/blind (n=556) 90 15.00 
Non-verbal (n=559) 86 14.40 
Self-Help (n=560)    
Not able 151 25.20 
Partly able 224 37.40 
Able 185 30.90 
Mobility (n=560)   
Non-ambulant 58 9.70 
Partly-ambulant 64 10.60 
Ambulant 438 72.80 
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Comparisons of the GDQ score between children with and without GORD 
were carried out using a Mann-Whitney U analysis. The relationship between GORD 
and the identified factors was explored using a t-test applied to regression factor 
scores. To explore sensitivity and specificity and inform the choice of a clinical cut-off, 
a Receiver Operating Charactistics (ROC) analysis was conducted. Youden’s Index 
(YI) was calculated for each of the potential cut-off values. YI gives a metric between  
zero and one indicating the balance between sensitivity and specificity of a measure 
(Fluss, Faraggi & Reiser, 2005; Liu 2012). A YI of  one would indicate a measure 
which successfully identified every person with GORD without wrongly mislabelling 
any individual without GORD as having it. 
Finally, a series of Chi2 analyses were conducted to explore associations 
between the proposed clinical cut-off and the presence of painful health problems, 
including GORD. To account for multiple analyses the alpha value was adjusted to   
α = .001. Odds Ratios (OR) were calculated for any health problems that returned a 





2.3.2.1. Analysis of GDQ factor structure. 
To achieve the first aim of exploring the structure of the GDQ, analyses were 
carried out on the individual GDQ items. Bartlett’s test of sphericity was found to be 
significant (X2 = 2007.48, p < .001) supporting the hypothesis that the items fit an 
identity matrix making the GDQ amenable to factor analysis. The high value found in 
the Kaiser-Meyer-Olkin test confirm the sample as being sufficient for factor analysis 
(KMO = .84). The PCA identified a five-factor solution, seen in Table 18, which 
accounted for 54.36% of the variance5. All 17 of the GDQ items loaded on to at least 
one factor. One GDQ item, item 11 which asks how often the child cries, moans or 
otherwise appears to be in pain, loaded across multiple factors, contributing to both 
factors one and three. 
  
                                            
5
 Although 60% is often cited as the minimum level of variance to consider factor analysis acceptable, 
it is not uncommon to consider models which explain 50-60% in the social sciences (Hair, 2014).  
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Table 18: Five factor solution produced by PCA with varimax rotation, including 
contribution of each factor to the 54.36% of variance explained by the model. 
 
Factor Loadings 
1 2 3 4 5 
Item 5. Place their hands or fingers in back of their mouth .77     
Item 6. Chew on his/her clothes, fingers, hands or other 
parts of the body, objects or material 
.66     
Item 3. Salivate excessively .63     
Item 7. Grind their teeth .54     
Item 8. Scratch/hit/press/rub around the upper chest/throat .52     
Item 10. Cough, gag or regurgitate .51     
Item 2. Lie over an object on his/her stomach  .82    
Item 1. Arch his/her back, lie over arms of chairs or people  .75    
Item 4. Fidget, wriggle or move their body a great deal  .58    
Item 13. Appear indecisive about food    .80   
Item 12. Refuse food even though they are probably hungry   .79   
Item 11. Appear in pain or discomfort (cry, groan or moan) .41  .45   
Item 9. Drink/request/seek out an excessive amount of fluids    .73  
Item 16. Bad breath    .64  
Item 14. Wake during the night    .41  
Item 17. Experience frequent respiratory infections     .77 
Item 15. Sleep sitting or propped up     .57 
Total contribution of component to model (%) 15.89 11.46 10.55 8.83 7.64 
 
2.3.2.2. Analysis of validity. 
To explore the second aim to explore the GDQ’s ability to identify children 
who may be experiencing GORD, the total score and factor level scores on the GDQ 
were compared to parental rating of gastric reflux in the last month from the Health 
Questionnaire. The data presented in Table 19 demonstrate that children with 
caregiver reported GORD had significantly higher total scores on the GDQ and 
significantly higher scores on Factors one, three, four, and five of the GDQ. The 




Table 19: Median (IQR) of GDQ total and regression factor scores for those with and 
without recent GORD according to caregiver report, with associated Mann-Whitney 





Whitney U / t 





































2.3.2.3. Sensitivity and specificity of GDQ cut-off values. 
In order to answer the third research question and establish a suitable clinical 
cut-off for the GDQ, a ROC analysis was conducted. Given the results of the PCA, 
the ROC analysis in Figure 8 included both the full total of the GDQ as a sum of all 
item vales, as well as an adjusted total which omitted the items contributing to factor 
two which was demonstrated to be non-significant (see Table 18, above). Area under 
the curve was 0.73 (p < .001) for the GDQ total score and 0.75 (p < .001) for the 
adjusted score. Results from the Youden’s Index analysis are presented in Table 20. 
The best YI achieved was YI = .39, using the adjusted GDQ total with cut off of > 8 
where a score of nine or more is seen as indicative of potential GORD. This equates 
to a sensitivity of .83, and specificity of .56. In all the following analyses, the cut off of 




Figure 8: ROC curve for GDQ total and adjusted total calculated by omitting items 





Table 20: Sensitivity, specificity, and Youden’s Index scores for potential cut off 
values on the GDQ with all items summed, and the adjusted sum with items  one, 
two, and four omitted 
GDQ total GDQ adjusted total 
Cut 
off 





value Sensitivity Specificity 
Youden’s 
Index 
> 10 .85 .47 .32 > 7 .86 .50 .36 
> 11 .83 .52 .35 > 8 .83 .56 .39 
> 12 .82 .55 .37 > 9 .79 .59 .38 
> 13 .80 .57 .37 > 10 .74 .62 .36 
> 14 .74 .60 .33 > 11 .69 .66 .35 
2.3.2.4. GDQ associations with other painful health problems. 
The final research question was addressed with a series of Chi2 and odds 
ratio (OR) analyses to examine whether the GDQ score associated with GORD 
specifically or whether it may also be associated with other health problems 
experienced by the child in the previous month. Using the clinical cut-off of > 8 
recommended by the YI (see Table 20, above), participants were grouped into those 
who scored above and those who scored below clinical cut off. The presence of 
physical health problems in these two groups was then compared.  
The results in Table 21 show that those with parent reported GORD, bowel 
problems, epilepsy, respiratory problems, and skin problems were significantly more 
likely to score above the cut-off on the GDQ. No significant differences were found 
between children above and below GDQ cut-off in the rates of diabetes, liver or 
kidney problems, ear problems, or heart problems. The OR calculations show that 
the odds of a child having parent reported GORD if they score above cut off on the 
GDQ are six times the odds of a child having parent reported GORD if they scored 
below cut off. The OR was slightly lower for bowel problems and respiratory 
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problems (OR = 5.05 and 4.84 respectively), and considerably lower for epilepsy 
(OR = 2.19), and skin problems (OR = 1.99). 
Table 21: X2 and Odds Ratio analysis of health problems in the last month, 
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597 47 263 21 266 9.09 < .01 
2.26 
[1.32, 3.89] 










597 14 297 7 279 1.85 .17 - 
Diabetes 595 8 301 2 284 3.21 .07 - 
Liver/Kidney 
problems 
599 20 292 9 278 3.48 .06 - 
1 GDQ question 17 removed due to potential confound 







2.4. Study Two 
Study Two aimed to explore the feasibility of a brief observational screening tool 
for use in clinical settings by addressing the following aims: 
1. To explore whether behaviours reported by parents/caregivers on the GDQ 
can be detected in brief observation by a naïve observer 
2. To evaluate the degree of association between GDQ scores obtained from 
parent / caregiver report and observation by a naïve observer 
3. To explore whether scores obtained from brief observation by a naïve 
observer can differentiate children whose GDQ scores fall above and below 
the clinical cut-off derived in Study One. 
 
2.4.1. Method 
Participants from previous Cerebra Centre studies for whom both video 
footage and GDQ data were collected were identified for potential inclusion in the 
study. The footage reviewed had never previously been investigated for behaviours 
indicative of GORD. The observers responsible for rating the behaviours in the 
current study had no involvement in the original studies and had no interaction with 
the children or families and therefore were naïve observers. The observers were 
blinded to the GDQ scores until all videos had been coded. 
For each child, ten minutes of video footage was selected for coding. Some of 
the studies had recorded several different naturalistic and experimental paradigms, 
therefore a selection hierarchy was developed to guide footage selection. The 
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hierarchy aimed to capture naturalistic behaviour and, where possible, avoid 
capturing the effects of experimental manipulation on behaviours. The hierarchy also 
sought to avoid inclusion of distress that may be directly induced by task demands or 
biased selection of footage which showed disproportionate levels of distress. As 
such, the obtained video clips were considered to be representative of children’s 
typical behaviour. 
The different experimental paradigms included in the original footage are 
briefly described below. The experimental paradigms and recruitment strategies are 
reported in greater detail in the original studies (Arron et al., 2011; Oliver et al., 2011; 
Richards et al., 2012). 
Autism Diagnostic Observation Schedule: (ADOS; Gotham, Risi, Pickles & 
Lord, 2006) The ADOS is a behavioural assessment used to elicit typical social 
behaviours in order to investigate potential autism related behaviours. The ADOS 
includes a minimum of two minutes of free-play, and the prescribed sections of the 
assessment are play activities for the children. The free-play was included in the 
selected footage for all participants for whom ADOS footage was used. ADOS 
footage was used for 18% of participants (n = 9).  
Social presses: The social presses is a series of play sessions with some 
scripted tasks such as tower building and ball throwing. Included in the current study 
were the ‘Responsive Engagement’ condition, in which the adult in the play session 
responds appropriately and naturalistically to any interaction initiated by the child, 
and the ‘Active Engagement’ condition, in which the adult actively engages the child 
in play. Conditions in which the adult ignores interactions from the child, or places 
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explicit task demands on the child, were excluded due to the potential for distress. 
Social presses footage was used for 53% of participants (n = 26). 
Experimental functional analysis analogues: The EFA analogues are a series 
of social interactions, designed to examine a child’s response to social engagement, 
task demand, and being ignored. There are no toys provided or tasks presented to 
the child. Only the ‘high attention’ control condition was used for the current study as 
this was thought to be the condition least likely to elicit distress for the majority of 
children. During the ‘high attention’ condition, the adult actively engages with the 
child without placing demands on them, and responds naturalistically to any child 
initiated interactions. Footage taken from EFA analogues was used for 20% of 
participants (n = 10). 
Naturalistic observation: Naturalistic observation footage describes footage 
taken of the children without any experimental manipulation, e.g. footage of the child 
playing at home, or classroom footage of a typical lesson. Naturalistic footage was 
the preferred footage for inclusion in the current study, but because it could only be 
used if the original study had included the routine collection of naturalistic footage in 
its protocol, it was the least frequently available footage. Footage of natural 
observations was used for 8% of participants (n = 4).  
2.4.1.1. Sample. 
After the coding scheme was established, the following inclusion criteria were 
applied to the available videos: 
1. Child aged between one and 18 years 
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2. A minimum of ten minutes of video footage available 
3. Child must be visible on screen for at least 90% of the duration of the footage 
4. A GDQ must have been completed by the parent/carer within one month of 
the video footage capture 
A total of 31 videos were excluded, the majority because the date of completion 
on the GDQ was more than a month from the date of the video recording. The final 
sample therefore included footage of N = 49 children whose demographic details are 
displayed in Table 22.  
Table 22: Age, sex, and known diagnoses for the N = 49 children included in study 
Two. 
 n % 
Age: Mean in years  
(range) 
9.94 
(2.00 - 18.00) 
- 
Gender   
Male 25 51.00 
Female 24 49.00 
Diagnosis   
Angelman Syndrome 14 28.60 
Cri du Chat 14 28.60 
Cornelia de Lange Syndrome 9 18.40 
Autism 10 20.40 
Smith-Magenis Syndrome 1 2.00 
Cerebral palsy 1 2.00 
2.4.1.2. Coding. 
An observational behavioural coding scheme was developed from the GDQ 
using an iterative process to identify a set of behavioural definitions relating to gastric 
distress that could reliably be coded by researchers. Observable behaviours 
reported in the GDQ were identified and operationalised. A sub-set of 25% of the 80 
videos available before exclusions were selected and coded independently by the 
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two naïve observers and inter-observer reliability was calculated. Items with low 
reliability were reviewed and the definitions were revised to better reflect the 
behaviours observed in the videos. Some behaviours were combined into one code 
due to the difficulty of accurately and reliably differentiating between similar 
behaviours in video footage, for example, putting fingers in back of mouth, and 
chewing on fingers/hands. The videos were then re-coded by both researchers used 
the final coding scheme, which produced a good level of reliability (mean kappa 
= .78, range .61 - 1.00). The final coding scheme is presented in Table 23.  
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Table 23: Final coding scheme with levels of agreement reached. Where kappa is not reported behaviour was not observed in any 






Operationalised description Kappa 
Back arching 1 Duration 
A significant movement bending backwards or pushing the chest forwards in a 
way that creates an arch in the back 
.97 
Lying on object or 
person 
1 Duration 
Lying down with back bent over/on top of an object, item of furniture or person 
in such a way as to create an arch in the spine 
1.00 
Lying prone on object 
or person 
2 Duration 
Lying down with stomach bent over/on top of an object, item of furniture, or 
person in such a way as to create a bend in the spine 
.91 
Salivation 3 Duration 
Visible saliva e.g. saliva on face or spitting, duration code ends (i) when saliva 
on face is no longer visible for any reason (e.g. head turns away, saliva dried 
or wiped), (ii) saliva is still visible but not on face e.g. spitting saliva on to 
surface, code ends when spitting stops 
.70 
Swallowing 3 Frequency Visible swallow or audible gulping noise in the absence of drink/food - 
Repetitive hand 
movements / Hand 
fidgeting 
4 Duration 
Repetitive movements of the hands, arms, and/or fingers without an apparent 
function. Do not code where the movement appears to be an exaggeration or 




movements / Body 
fidgeting 
4 Duration 
Repeated movements of the body (excluding hands and fingers, see hand 
fidgeting) which appear to lack a clear function. Do not code where the 
movement appears to be an exaggeration or repetition of a communicative or 
functional action, or where the action is a direct response to an external 
stimulus (e.g. jiggling about in response to being tickled) 
.71 
Hands in mouth 5 & 6 Duration 
Placing fingers or hands in the mouth, either with or without visible chewing 
occurring 
.76 
Chewing on clothes or 
object 








Operationalised description Kappa 
Teeth grinding 7 Duration 
Either one or both of: Visible grinding of teeth - jaws clenched with movement 
in lower jaw, audible grinding of teeth - audible scraping noise in the absence 
of any other obvious source 
.87 
Chest contact 8 Duration 
Intentional direct contact (including scratching, hitting, pressing, rubbing) using 
a body part or object to any area below the chin and above the ribs. Exclude 
where contact is an action of wider communication e.g. Makaton, BSL. 
.78 
Drink 9 Frequency Seeking out a drink or visibly drinking - 
Coughing 10 Frequency Visible or audible cough  .75 
Gagging/Regurgitating 10 Frequency 
choking or retching noise or visible difficulties in swallowing accompanied by a 
forward motion in the shoulders 
- 
Crying 11 Duration 
Sobbing or crying with or without visible tears, with a facial expression 
indicating distress e.g. two lines on the forehead, a furrowed brow 
.89 
Groaning/moaning 11 Duration 
A sustained low pitch noise accompanied by a distressed facial expression 





Saying pain associated word such as "ouch" or using Makaton sign or picture 
symbol to communicate pain to others. Only code Makaton sign where there is 
clear evidence that this is the intention of the movement. e.g. use of other 




Behaviours were coded live using Obswin behavioural coding software 
(Martin, Oliver & Hall, 1998). Twelve of the 17 behaviours were coded as duration 
variables, meaning that the length of time that the child spent engaged in the 
behaviour was recorded, e.g. length of time spent lying prone on an object. Five 
behaviours were coded as frequency variables, meaning that only a frequency count 
for the behaviour was kept, e.g. recording the behaviour of coughing as the number 
of individual coughs, as opposed to length of time spent coughing. 
2.4.1.3. Analysis strategy. 
Coding of the full sample of videos was conducted using OBSWIN software 
(Martin, Oliver & Hall, 1998). Ten minutes of footage was coded for each child. Initial 
exploratory analysis of the frequency of behaviours within the sample was conducted.  
Further analysis was conducted using the total number of behaviours shown 
by each child, the total frequency of behaviours across all behaviour types, the 
number of seconds spent engaged in any behaviour, and the percentage of time 
spent engaged in each behaviour. The different observational scores were compared 
to parent/caregiver GDQ scores using Spearman Rho correlations and to groups 
above and below the GDQ clinical cut-off, calculated in study one, using Mann-







2.4.2.1. Exploratory analysis of types and frequency of observed 
behaviours. 
To explore whether the behaviours reported on in the GDQ can be detected 
by a naïve observer in a brief period of observation an initial exploratory analysis of 
the frequency of observed behaviours was conducted, displayed in Figure 9. The 
majority of children (n = 28) engaged in between two to four different target GDQ 
behaviours in the course of a ten minute observation period. Table 24 displays the 
rates at which each of the behaviours were observed in the sample. The most 
commonly observed behaviour was hand fidgeting which was displayed by more 
than half of the sample (n = 29). Swallowing, gagging and drinking behaviours were 
not displayed by any of the children observed.  
 


















Number of behaviours observed 
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Table 24: Summary statistics associated with each observed behaviour; number of 
children observed engaging in behaviour; mean frequency of behaviour in 10 minute 
observation; total duration engaged in behaviour (s); duration engaged in behaviour 
as % of 10 minute observation period 













































































































Lying on object or 
person 
1 1.00 13.00 2.17 
Teeth grinding 1 1.00 3.00 0.50 
Swallowing 0 - - - 
Drink 0 - - - 




2.3.2.2. Comparison of observations against GDQ scores. 
To address the second aim, the degree of association between GDQ scores 
obtained from parent / caregiver report and behaviours coded by a naïve observer 
was evaluated. The results of the Spearman’s Rho correlations shown in Table 25 
indicate that there were no significant associations between any of the coded 
behaviours and the adjusted GDQ total scores.  
Table 25: Spearmans Rho correlations of adjusted GDQ score (items  one, two, and 
four ommitted) compared to total number of different types of behaviour recorded in 
ten minute observation; combined frequency of behaviours across all behaviour 
types; total duration engaged in any behaviour in seconds; total duration engaged in 













in any behaviour 
(%) 
r .10 .04 .08 .08 
p .48 .79 .58 .58 
Fidget behaviours were observed at very high frequency in behavioural 
observations, yet analysis in Study One (see Section 2.2.2) suggested that fidgeting 
behaviours were not associated with GORD. Therefore, to ensure that putative 
associations between observed behaviours and parent/caregiver GDQ were not 
obscured by the high frequency fidgeting behaviours, all correlations were replicated 
without hand and body fidgeting behaviours.  The results in Table 26 demonstrate 
that no associations were identified between the coded behaviours and the adjusted 




Table 26: Spearmans Rho correlations of adjusted GDQ score (items  one, two, and 
four ommitted) compared to total number of different types of behaviours, excluding 
hand and body fidgeting behaviours, recorded in ten minute observation; combined 
frequency of behaviours across all behaviour types; total duration engaged in any 














in any behaviour 
(%) 
r .11 .05 .05 .05 
p .48 .75 .71 .76 
 
2.3.2.3. Observed behaviours in children above and below GDQ cut-off. 
Finally, to explore the potential association between coded behaviours and 
the GDQ cut-off a series of Mann Whitney U analyses were comparing coded 
behaviours between those children scoring above and below cut off on the GDQ. 
The results in Table 27 reveal that there were no significant associations between 







Table 27: Median, IQR, and Mann-Whitney U analysis grouped by children above 
and below clinical cut off on GDQ. Observation scores calculated as total number of 
different types of behaviour recorded in 10 minute observation; combined frequency 
of behaviours across all behaviour types; total duration engaged in any behaviour in 
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The studies reported here set out to explore and the utility of the GDQ as a 
tool to screen for GORD symptoms in children with ID. Study One aimed to explore 
the underlying structure of the measure and recommend a cut-off point which might 
provide adequate sensitivity and specificity for screening purposes. Study Two 
aimed to explore the feasibility of developing an observational version of the GDQ for 
use in primary care settings. The use of existing data allowed for an initial 
exploration of the validity of the GDQ without exposing participants to invasive and 
potentially unnecessary medical procedures.  The inclusion of multiple data sets 
produced a reasonable sample size adequate for factor analysis, and allowed the 
inclusion of multiple genetic syndromes, reflective of the heterogenous nature of the 
ID population. The results of Study One revealed that there were significant 
differences in GDQ scores between children who had and had not experienced 
GORD recently. Study One also established a scoring strategy and clinical cut off for 
the GDQ which achieved a sensitivity score of .86. Study Two demonstrated that the 
application of the GDQ as a brief observational tool for a naïve observer does not 
correlate to parent/carer reported GDQ scores. Similarly, Study Two also 
demonstrated that observed coded behaviours do not differentiate between children 
who score above and below cut off on the GDQ. These findings suggest that brief 
observation by a naïve observer may not be sufficient to identify behaviours which 
are indicative of GORD in children with ID. 
The first goal of Study One was to explore the factor structure of the GDQ, as 
this had not been undertaken previously. Five factors were identified using an 
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exploratory factor analysis approach. Factor one was identified as the factor which 
contributed most to the model and included items relating to chewing, salivating, 
putting fingers in mouth, grinding teeth, scratching at the throat, crying and coughing. 
The selection of items included in factor one suggest that factor one scores may be 
indicative of distress and pain located in the mouth and throat. Factor two included 
the behaviours of lying on the stomach, arching of the back, and fidgeting. Based 
upon the inclusion of back arching and fidgeting, the co-occurance of which was 
referred to as “a non-verbal equivalent of heartburn” by Czinn and Blanchard (2013), 
one might conclude that factor two scores were indicative of heartburn. However, if 
factor two scores were heartburn related then a significant difference in factor two 
scores between children with and without a reported diagnosis of GORD would have 
been expected (Hassal, 2001; NICE, 2015). Given that such a difference was not 
found, it is plausible that factor two relates to either generalised pain related 
behaviours, stereotyped and repetitive behaviours, or hyperactivity, which are 
commonly reported in children with ID (Taanila, Ebeling, Heikura, & Järvelin, 2003). 
Factor three groups together children refusing food, appearing indecisive about food, 
and crying. The grouping of behaviours in factor three appears to be related to 
changes in appetite and meal time behaviour. Factor four groups together several 
known indicators of GORD; night waking, bad breath, and increased fluid intake. 
Based upon the grouping of these three behaviours, factor four may detect cases 
involving sleep problems such as sleep apnea. A review of the literature suggests 
that GORD and sleep apnea may exist in a mutually reinforcing relationship 
(Demeter & Pap, 2004). Factor five groups the remaining items; frequency of 
respiratory infection, which has a known association with GORD (Reyes, Cash, 
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Green & Booth, 1993), and sleeping seated or propped up at night. Study one has 
identified a factor structure which fits with the current understanding of GORD. There 
may be potential that with further study the underlying factors of the GDQ could 
improve the usefulness of the tool and aid definition and delineation of atypical 
variants of GORD.  
The second aim of Study One was to explore the validity of the GDQ as a tool 
for detecting GORD. The results of Study One demonstrated significant differences 
in both the total GDQ scores, and all factor scores except factor two, between 
children with and without a reported diagnosis of GORD. This was further supported 
by the ROC analysis which produced a significant area under the curve score for 
both proposed methods of scoring the GDQ. The findings of Study One establish 
that the GDQ is capable of distinguishing between children with and without GORD 
according to parental report of diagnosis. Although parental report of diagnosis is not 
equivalent to medical diagnostic procedures, the significant association between 
GDQ scores and parental report of diagnosis reported here offers an important 
indicator that the GDQ is a promising tool requiring further clinical validation. The 
findings of Study One suggest that the GDQ may be a potentially useful tool in 
supporting clinicians to identify children who would benefit from further investigation 
of GORD symptoms. It is important that GORD is detected and treated in people 
who cannot self-report their symptoms, given the established associations between 
untreated pain, behaviours that challenge, and reduced quality of life (Carr & 
DeSchryver, 2007; Wiggs & Stores, 1996; Beadle-Brown, Murphy & DiTerlizzi, 2009). 
A study comparing GDQ scores to GORD diagnosis, as established by gold standard 
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medical procedures, is now required in order to support a recommendation for the 
GDQ as a tool to be used in clinical practice.  
The results of Study One also established a clinical cut-off for the GDQ. The 
cut-off suggested by Youden’s Index (YI) was > 8 which produced a sensitivity of .83 
and a specificity of .56. This cut off should be applied to the amended total which 
omits items one, three and four. Similar sensitivity and specificity can also be 
achieved using a cut-off of > 12 for the full GDQ score. YI is a purely statistical 
strategy for determining cut-off choice and does not include any clinical judgement. A 
perfect test would produce both sensitivity and specificity values of 1, but the reality 
is that sensitivity is necessarily gained at the expense of specificity, or specificity at 
the expense of sensitivity (Watson & Petrie, 2010). For the purposes of a screening 
test, correct identification of children who may be displaying GORD symptomology 
(sensitivity) is more important than exclusion of children are not displaying such 
symptoms (specificity). Although one would not wish to expose children 
unnecessarily to the invasive health procedures required to confirm a GORD 
diagnosis, the GDQ is intended for use as a screening tool to be used alongside 
clinical judgement rather than being used as a diagnostic tool in isolation. The 
primary purpose of the GDQ is to support clinicians in recognising GORD symptoms 
in children who may otherwise go undiagnosed. As discussed in the introduction, the 
potential consequences of failing to detect GORD can be severe both in terms of 
behavioural consequences (Carr & DeSchryver, 2007; Allen, Lowe, Brophy & Moore, 
2009; Beadle-Brown, Murphy & DiTerlizzi, 2009), and potential health consequences 
(Solaymani-Dodaran, Logan, West, Card & Coupland, 2004). Thus in the case of the 
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GDQ it is justifiable, and arguably preferable, to use a cut-off with sub-optimal 
specificity in order to maximise sensitivity. 
The final aim of Study One was to explore the discriminant validity of the GDQ. 
The results of Study One found no association between GDQ scores and diabetes, 
liver problems, or heart problems as reported in the previous month. However there 
were significant differences in the rates of GORD, bowel problems, epilepsy, 
respiratory problems, and skin problems between children above and below GDQ 
cut offs. Importantly, the analysis of the strengths of the differences in scores utilising 
odds ratios, demonstrated that the odds ratio of a child above clinical cut off were 
higher for GORD than for any other assessed health problem, suggesting some 
discriminant validity for the GDQ. Many of the other health conditions which are 
associated with scores above clinical cut off on the GDQ have a known overlap with 
GORD, either because of shared symptoms or because they are commonly co-
morbid. Bowel problems such as Irritable Bowel Syndrome (IBS) are known to be a 
common co-morbidity of GORD, occurring in nearly half of GORD patients (Kennedy 
et al., 1998; Frissora & Kick, 2005). Similarly, there is a body of literature evidencing 
the links between respiratory problems and GORD, with GORD thought to be a 
potential cause of respiratory infection in some cases.  
Study One utilised historical data in the assessment of the GDQ. A key 
limitation is that no direct clinical data were collected, instead Study One is reliant on 
the accuracy of parental reports. Hence assumptions are made that parents have 
either received a clinical diagnosis of GORD for their child, or have identified recent 
symptoms being experienced by their child, many of whom are minimally verbal, and 
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correctly identified those symptoms as being indicative of GORD, something which it 
has already been acknowledged, even clinicians sometimes struggle with. However, 
by making use of these historical data, Study One has achieved a large and diverse 
sample. Had the current study recruited a new sample specifically for the purposes 
of assessing the GDQ, it is unlikely that as many children would have been recruited 
as have been reported here. Study One has demonstrated a five factor structure 
underlying the GDQ, and has recommended a new scoring strategy, omitting items 
one, two and four which show no significant associations with recent GORD. Using 
the new scoring strategy a clinical cut off has been recommended which shows 
adequate sensitivity and specificity for using the GDQ as a screening tool to identify 
children who might benefit from further medical investigation of GORD. Further 
research is needed to assess the utility of the GDQ in medical settings, and to test 
the suggested cut off against clinical diagnosis of GORD as opposed to parent report, 
however the current study has provided adequate evidence to suggest that such 
research would be a worthwhile endeavour. 
Study Two explored the feasibility of a brief observer version of the GDQ 
which could be used by a naïve observer such as a clinician. The development of a 
coding scheme based on behaviours from the GDQ, and establishing of acceptable 
kappa values between two naïve observers, suggest that many of the behaviours 
from the GDQ can be reliably observed, even by people who are unfamiliar with the 
child. Some of the items from the GDQ could not be developed into corresponding 
observational codes because they were not explicit behaviours, such as bad breath, 
or respiratory infections. Other items were unlikely to be observed given the nature 
of the footage being used, such as those items relating to behaviour around food or 
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sleeping. Finally, three items were developed into codes, but were not observed in 
any of the analysed footage; swallowing, drinking, and gagging/regurgitating. The 
most commonly observed behaviours were fidget behaviours. Both fidgeting with the 
hands and fidgeting with the body, such as bouncing or swinging legs, were 
observed in at least half of the sample. The high frequency of fidgeting in Study Two 
gives some credence to the argument that fidgeting may generally be a high 
frequency behaviour in this population, which could mean that it might not be as 
useful an indicator of pain as it is in typically developing children (Czinn & Blanchard, 
2013). Fidgeting or restless behaviours may only be indicative of pain in cases 
where they represent a deviation from the child’s usual presentation, which would 
rely upon the knowledge of someone such as a caregiver who knows the child well. 
The primary results of Study Two demonstrated that whilst many behaviours 
from the GDQ were observable, the scores acquired through observation were not 
associated with parent/caregiver GDQ scores. This finding may begin to offer some 
explanation as to why GORD might be under diagnosed in children who cannot self-
report pain. It may be that brief observation might not be sufficient for detecting the 
behaviours which are most indicative of GORD, making it difficult to detect GORD 
related behaviours in a routine clinical appointment. However, there are limitations to 
the current study. Study two, similar to study one, was conducted using historical 
data, in order to achieve an adequate sample size, multiple experimental paradigms 
were included in the footage which was selected for analysis. Although attempts 
were made to limit the inclusion of experimentally induced stress behaviours in the 
analysed footage, this cannot be guaranteed. It is also of note that within the sample 
the group of children who scored above cut-off on the GDQ was relatively small. In 
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conclusion, while study two might suggest that the use of the GDQ items to inform 
observation by a naïve observer does not yield the same results as parent report, the 
study is by no means robust enough to draw any larger conclusions regarding the 
usefulness of observation as a means of detecting GORD. The results of study one 
indicate that there are behavioural indicators of GORD which can be detected, it 
might be that parents are best placed to notice these behaviours, but that does not 
mean that clinicians could not be enabled to do so also, given the right tools. Further 
research to this end may still be of significant clinical benefit. 
Health inequalities remain a key concern for those seeking to improve the 
lives of people with ID. Improved tools and training for clinicians are clearly required 
in order to improve recognition and diagnosis of treatable disorders in people with ID, 
and the studies reported here suggest that the GDQ may be one tool to improve 
recognition of gastric pain in this population. However, these studies also highlight 
the importance of parent or caregiver knowledge in the diagnostic process. 
Unfortunately, increasing the contribution that caregivers can make to the diagnostic 
process is not something that can be easily resolved. Parents and caregivers, when 
they are available, already frequently act as knowledgeable advocates for the people 
under their care, but the literature suggests that they may not always be consulted, 
or their reports may not be believed (Lewis, Gaffney & Wilson, 2017). Tools such as 
the GDQ may help to address this by formalising the caregiver report into a validated 
measure that a clinician can easily interpret. However addressing the broader issue 
of increasing the collaboration between health care professionals and care givers 
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CHAPTER THREE, PUBLIC BRIEFING DOCUMENT: 




3.1. Assessing pain through behavioural observation – why bother? 
Everyone experiences pain differently, our experience of pain can be affected by our 
emotions, our expectations, and our previous experiences of pain or injury. Because 
of this, subjective ratings of pain are considered to be the “gold-standard” for pain 
assessment, even very young children will be asked by clinicians to provide their 
own ratings for their pain. However, not everyone can provide their own ratings, 
people might struggle to understand the rating system they are given, or they might 
have difficulty in communicating. But if we don’t have accurate ways to assess 
people’s pain without self-report then some people’s pain might be left untreated. 
Untreated pain can have serious negative consequences, it can affect our mood, our 
sleep, and our health. 
When people aren’t able to self-report, usually someone else will attempt to judge 
how much pain they are in by looking at how they are behaving, for example, if 
someone is crying then we might think they are in more pain than if they are sitting 
quietly.  
This document summarises research carried out by a Trainee Clinical Psychologist 
at the University of Birmingham that (i) explores and evaluates the tools researchers 
use when they are trying to observe pain, and (ii) assesses a new measure which is 







3.2.1. What is a meta-analysis? 
A meta-analysis is a way of bringing together all of the available data that has been 
collected on a certain topic. The findings are taken from each study that has 
researched the question, and put together into an analysis which tells us the average 
finding, taking into account things like how many people were recruited for each 
study, and the quality of each study.  
3.2.2. What were you trying to find out? 
The aims of the meta-analyses were: 
1. To identify the most common observational assessments used in 
published studies that seek to quantify pain in children 
2. To find out how well the most commonly used observational assessments 
compare to self-reports of pain. 
3.2.3. What did you do? 
Five databases were searched for words relating to “pain” “assessment” and 
“children”. All of the papers were reviewed to check they used observational 
measures to assess pain in children aged 1-18 years. Then all of the observational 
measures were recorded, along with how many studies used them. 
Once all of the studies had been reviewed, papers were identified that reported a 
correlation between any of the five most common observational measures, and self-
report measures of pain. The results of those correlations were put into a statistical 
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programme to calculate a weighted average, a figure that attempts to summarise the 
overall findings of the literature. 
3.2.4. What did you find out? 
What tools get used? There were 526 published studies that used observational 
measures to assess pain in children, and nearly a third of those studies used either 
the Children’s Hospital East Ontario Pain Scale (CHEOPS; McGrath et al., 1985), 
the Visual Analogue Scale (VAS; Price, McGrath, Rafii & Buckingham, 1983), the 
Face, Legs, Activity, Crying and Consolability (FLACC; Voepel-Lewis, Shayevitz & 
Malviya, 1997), the Observer Pain Scale (OPS; Hannallah et al., 1987), or the Wong-
Baker Faces Scale (WBF; Wong & Baker, 1988). Even though one of these five 
measures were used most of the time, there were still 62 different measures that 
were named, most of those measures were only used by one or two studies each. 
How well do observational pain measures correlate to self-report? The table 
below shows the results of the meta-analysis. The measure that correlated best to 
self-report was the WBF, but there were only four studies available that tested this, 
two of them had very low scores, and two of them had very high scores, so there 
was a lot of variability. This might be because the WBF was originally designed as a 
child-friendly tool for self-reporting pain, so it does not give the person using it any 
specific behaviours to look for. Because of that it is easy for people to interpret it in 
lots of different ways which might produce a lot of different results. 
The FLACC scored slightly lower than the WBF with regards to correlation to self-
report, however, there were more studies available which assessed this, and the 
finding was much more consistent across those studies. The FLACC is specifically 
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designed as an observational assessment, and directs the user towards specific 
behaviours to score in order to produce the pain rating. 
3.2.5. Conclusions 
The Pediatric Initiative on Methods, Measurement, and Pain Assessment in Clinical 
Trials (PedIMMPACT) group only recommends seven different observational 
measures for use in clinical trials involving children (Von Baeyer & Spagrud, 2007), 
this is because, having reviewed the literature, they found that only seven measures 
had enough evidence to demonstrate that they were reliable and valid measures of 
pain. The FLACC and CHEOPS both feature in the PedIMMPACT recommendations, 
so it is positive that they are among the most commonly used measures. However, it 
also makes the number of measures identified in this review very concerning; if only 





3.3. Empirical Study 
3.3.1. What were you trying to find out? 
The aims of this study were: 
1. To find out more about the Gastric Distress Questionnaire (GDQ) and how 
useful it could be as a screening measure for Gastro-oesophageal Reflux 
Disease (GORD) 
2. To try to create a brief version of the GDQ that could be used by someone 
who does not know the child, for example, a nurse or doctor, to help them 
decide whether or not to refer the child for more specialist assessment 
3.3.2. Who would that help? 
GORD is a painful health condition, it happens when stomach acid keeps being 
brought back up into the oesophagus. Most people will experience reflux once in a 
while, particularly when they are very young, but when it keeps on happening over a 
much longer period of time it is called GORD, and this can be painful and can have 
much longer term health consequences. GORD seems to be much more common in 
people with ID than it is in the general population, but it also frequently goes 
undiagnosed and untreated, because of the difficulties some people with ID have in 
reporting their symptoms. If family members, carers, and clinicians had the tools to 
recognise when someone with ID was experiencing the pain associated with GORD, 




3.3.3. What did you do? 
Firstly historical data from several previous studies was compiled. In all of the 
included studies, parents of children with ID had been asked about their child’s 
recent health, including whether they had experienced GORD in the last month or 
not, and the parent had completed the GDQ. In total data from 599 children was 
collected. The results were then analysed to assess whether there was any 
difference in scores between children whose parents had reported having GORD 
recently, and those whose parents said they had not had GORD. 
Factor analysis was carried out to look at how the different questions on the GDQ 
grouped together. An analysis of sensitivity and specificity was also carried out to 
help recommend a cut-off score that would make sure most children who did have 
GORD got picked up, without wrongly identifying too many of the children who did 
not have GORD. 
To try to develop an observational tool, the questions from the GDQ were converted 
into detailed and specific descriptions of behaviours. Footage was then collected 
from previous studies where parents had completed the GDQ. For each child ten 
minutes of video footage was viewed, and researchers recorded every time a child 
did one of the behaviours, for example, putting their fingers or hands into their mouth. 
The researchers looked at how different behaviours they observed in each child, how 
many times they observed any behaviour from each child, and how many seconds 
out of the ten minutes the child spent doing any of the behaviours that were being 
recorded. These different behavioural scores were all compared to the GDQ score 
provided by the parents. 
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3.3.4. What did you find out? 
Overall, higher scores on the GDQ were found in children with GORD than those 
without. The questions on the GDQ were found to group together into five groups, or 
factors. Factor two, which contained items asking if the child lies on their back, on 
their front, or fidgets a lot, was not found to relate to GORD, but all of the other 
factors were.  
The best cut-off value identified was found by adding together all of the question 
scores except for the questions in factor two. When the total is calculated in this way, 
a score of nine or more correctly identified eight out of ten children with GORD.  
The scores obtained through observation of the video footage did not show a good 
association with the GDQ scores. 
3.3.5. What does this mean? 
The GDQ could be a useful tool to help identify children who might benefit from 
medical assessment for GORD. However, because this study was based on parent 
reports of diagnosis, the findings are not enough to recommend that the GDQ be 
used in clinical practice. Further research is now needed to compare GDQ scores 
against actual medical assessments of GORD, but the current study does suggest 
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 This questionnaire asks about behaviours sometimes shown by people with learning disabilities.  
 Please read the questions and examples carefully and indicate how often each behaviour has 



























































1. Arch his/her back, lie over arms of chairs or people on his/her back?.......... 
4 3 2 1 0 
2. Lie over an object on his/her stomach? e.g. a side of an arm chair. ……………….  
4 3 2 1 0 
3. Salivate excessively? ……………………………………                                                              
4 3 2 1 0 
4. Fidget, wriggle or move their body a great deal? ……………………… 
4 3 2 1 0 
5. Place their hands or fingers in back of their mouth? ………………… 
4 3 2 1 0 
6. Chew on his/her clothes, fingers, hands or other parts of the body, objects or  
    material? ………………………………………………………………………… 4 3 2 1 0 
7. Grind their teeth? ……………………………………………………………… 
4 3 2 1 0 
8. Scratch, hit, press or rub around the upper chest or throat? ……………………… 
4 3 2 1 0 
9. Drink, request or seek out an excessive amount of fluids? ……………………… 
4 3 2 1 0 
10. Cough, gag or regurgitate? …………………………………………………… 
4 3 2 1 0 
11. Appear in pain or discomfort (cry, groan or moan)? …………………………… 
4 3 2 1 0 
12. Refuse food even though they are probably hungry? ………………………… 
4 3 2 1 0 
 
13. Does the person you care for appear indecisive about food (edging towards table or food then moving   
away repeatedly, taking food and putting it back)? (please tick)   
Yes            No  
 
 















16. Does the person you care for seem to have bad breath? 
 
Never Once a week At the same time everyday All day every day 
 
 
17. Has the person you care for prone to respiratory tract infections? (please tick)   
Yes                 No 
 
     If ‘yes’ please indicate how often they occur: 
      
Monthly  Quarterly Every six months Annually 
     
  
 
 Other (please specify)______________________________ 
  
Never Once a week Most nights Every night 
139 
 
Appendix B: Protocol for extraction of correlation values for meta-analysis 
Overlapping 
samples: 
In cases of multiple papers reporting the same sample then 
only one paper will be included. Selection will first be based on 
the paper reporting the most analysis of pain assessment will 
be selected, or if both papers report the same analyses, then 
the paper with the largest n will be chosen. 
Rater selection: In cases where correlation values are reported for multiple 
raters relating to the same child, clinician raters will be 
selected on the basis that the majority of obs scales are 
designed for clinical use. If multiple clinical raters are reported 
then most senior clinician will be selected. 
Self-report 
selection: 
If multiple self-report scales are reported separately then 
selection will be based on largest n first, or in the case of 
equal numbers then the scale which results in the best quality 
rating for the "self-report" domain will be usd 
Time selection: If multiple time points are reported then time point during 
painful procedure or time point that is closest to the 
completion of procedure will be selected 
Procedure 
selection: 
In cases where correlation values are reported for multiple 
painful procedures then both procedures will be reported 
separately if between group comparison, however for within 
group comparisons then control condition (condition which is 
described as replicating standard practice) will be selected to 
avoid inclusion of same child at multiple points in analysis 
Age selection: If multiple non-overlapping age groups are reported then each 














Appendix D: Reviewed literature for meta-analysis with included measures and sample details 






















Abdel-Ghaffar et al. (2011) Not 
named 
CHEOPS      no 36 60 84 
Abdelhalim et al. (2013) Researcher CHEOPS      no 120 36 84 
Abd-Elshafy et al. (2015 ) Not 
named 
OPS      no 50 48 144 
Abdul et al. (2017) Researcher SEM      no 50 48 96 
Abdulhameed et al. (1989 ) Clinician VAS      yes 30 96 168 
Acar et al. (2012 ) Researcher CHEOPS      no 50 24 120 
Akhtar et al. (2014) Researcher CHEOPS      no 60 60 144 
Akin et al. (2010 ) Not 
named 
CHIPPS      no 60 24 96 
Akinci et al. (2005) Clinician BPS      no 22 36 192 
Akkaya et al. (2009 ) Clinician OPS CRS4     no 66 36 108 
Akoglu et al. (2006 ) Clinician CHEOPS      no 46 24 144 
Alhashemi et al. (2006 ) Clinician OPS      no 40 36 180 
Alhashemi et al. (2007 ) Not 
named 
OPS      no 40 36 132 
Ali et al. (2013 ) Clinician CHEOPS      no 120 24 72 
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Al-Sadek et al. (2014) Not 
named 
CHEOPS OPS     no 108 36 84 
Alsadek et al. (2015) Not 
named 
OPS CHEOPS     no 60 24 84 
Alwugyan et al. (2007 ) Parent VAS      yes 281 72 144 
Al-Zaben et al. (2012 ) Not 
named 
OPS      no 60 12 84 
Aminabadi et al. (2008 ) Clinician SEM      no 78 48 60 
Aminabadi et al. (2011 ) Clinician SEM      yes 80 72 84 
An et al. (2017) Not 
named 
CHIPPS      no 100 12 72 
Anatol et al. (1997 ) Researcher CHEOPS      no 168 60 144 
Andersen et al. (2015 ) Clinician COMFORT      no 45 12 36 
Andrzejowski et al. (2002 ) Clinician CRS4      yes 133 60 144 
Anninger et al. (2007 ) Researcher MBPS      no 88 12 144 
Anouar et al. (2016) Clinician CHEOPS      no 40 12 48 
Antony et al. (2016) Not 
named 
OPS      no 50 12 96 
Apan et al. (2010 ) Researcher OPS      no 110 36 192 
Arts et al. (1994 ) Researcher GABR      yes 180 48 192 
Asaad et al. (2011) Not 
named 
CHIPPS      no 90 60 120 
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Asadi et al. (2016) Not 
named 
CHEOPS      no 98 36 144 
Ashkenazi et al. (2005 ) Clinician CHEOPS      no 193 24 156 
Ashkenazi et al. (2006 ) Clinician CHEOPS      yes 178 24 168 
Atabek et al. (2015 ) Clinician MBPS      yes 50 96 144 
Atef et al. (2008) Clinician OPS      no 40 36 120 
Ates et al. (1998 ) Not 
named 
MPOPS VAS     no 30 36 132 
Aydin et al. (2016 ) Parent & 
Clinician 
WBF      yes 120 84 144 
Babl et al. (2009 ) Clinician FLACC VAS     no 36 12 60 
Babl et al. (2012) Clinician FLACC      no 76 18 42 
Badali et al. (2000) Parent FACES      yes 23 60 144 
Baghdadi (1999 ) Not 
named 
SEM      yes 28 72 144 
Baghdadi (2000 ) Clinician SEM      yes 16 108 144 
Bahorski et al. (2015 ) Not 
named 
CHEOPS      yes 173 18 204 
Bai et al. (2004) Not 
named 
VAS OPS     no 91 12 168 
Bailey et al. (2015 ) Parent FLACC      yes 57 24 192 
Balan et al. (2009 ) Parent & 
Researcher 
VAS      yes  60 144 
Barkan et al. (2014 ) Parent VAS      no 60 12 120 
Bar-Meir et al. (2006) Clinician FLACC      no 59 12 192 
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Batra et al. (2003 ) Researcher OPS      no 120 24 96 
Baxt et al. (2004 ) Parent FACES CAS     no 276 60 204 
Baxter et al. (2011 ) Not 
named 
FLACC      no 51 12 36 
Bayon-Mottu et al. (2014 ) Parent & 
Clinician 
FLACC VAS     yes 107 27 226 
Bearden et al. (2012 ) Parent & 
Clinician 
VAS      yes 90 48 72 
Benini et al. (2004 ) Parent & 
Researcher 
VAS OWN     yes 16 84 216 
Benzon et al. (2015 ) Clinician FLACC      no 60 48 120 
Beran et al. (2007) Parent, 
Clinician & 
Researcher 
FPSR      yes 57 48 108 
Berberich et al. (2009 ) Parent & 
Clinician 
FPSR FLACC     yes 41 48 72 
Berde et al. (1991 ) Researcher CHEOPS      yes 35 36 84 
Bergendahl et al. (2004 ) Researcher OPS      no 104 22.8 116.4 
Beyaz et al. (2011 ) Not 
named 
FLACC      no 50 36 144 
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Beyaz et al. (2011 ) Not 
named 
CHEOPS      no 120 36 180 
Beyaz et al. (2012 ) Clinician CHEOPS      yes 100 36 180 
Beyer et al. (1990 ) Clinician CHEOPS      yes 25 36 84 
Bhatnagar et al. (2008 ) Researcher VAS      no 60 12 120 
Bhattacharya et al. (2005 ) Clinician VAS      no 50 96 144 
Birbicer et al. (2007 ) Not 
named 
CHEOPS OPS     no 60 24 120 
Birnie et al. (2016 ) Parent FPSR      yes 171 96 144 
Birnie, et al. (2017 ) Parent FPSR      yes 171 96 144 
Bishai et al. (1999 ) Parent & 
Clinician 
VAS      yes 39 60 192 
Bjorkman et al. (2012 ) Researcher FLACC      yes 29 60 180 
Blanchais et al. (2017 ) Clinician CHEOPS      no 21 18 60 
Boivin et al. (2008 ) Parent & 
Clinician 
CHEOPS VAS     yes 239 48 144 
Bolton et al. (2002 ) Clinician CHEOPS      yes 30 17 72 
Borazan et al. (2012 ) Clinician CRS4      no 120 72 156 
Borkar et al. (2005 ) Clinician OPS      no 50 36 156 
Bosenberg et al. (2003 ) Clinician CRS4      yes 110 46.8 144 
Brahmbhatt et al. (2012) Parent & 
Clinician 
NRS11      yes 33 48 192 
Breau et al. (2001 ) Parent & 
Researcher 
CFCS VAS     yes 123 52 80 
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Breau et al. (2002) Parent NRS11 NCCPC     no 101 36 216 
Breau et al. (2003 ) Parent NCCPC      no 101 36 216 
Breschan et al. (2005 ) Clinician CHIPPS      no 182 12 84 
Bridge et al. (2000) Not 
named 
CHEOPS      yes 30 48 144 
Bringuier et al. (2009 ) Parent & 
Researcher 
CHEOPS CHIPPS FLACC OPS   yes 150 12 84 
Brochard et al. (2009 ) Not 
named 
CHEOPS      yes 34 24 180 
Brudvik et al. (2017 ) Parent & 
Clinician 
NRS11      yes 243 36 180 
Burns-Nader et al. (2016 ) Researcher FLACC      yes 41 48 132 
Burns-Nader et al. (2017 ) Clinician NRS6      yes 30 48 144 
Burton et al. (1998 ) Clinician CHEOPS      no 30 24 84 
Caes et al. (2012 ) Researcher CFCS      no 56 132 180 
Cai et al. (2017 ) Parent PPPM      no 204 12 72 
Calis et al. (2014 ) Not 
named 
FLACC      no 60 72 144 
Canakci et al. (2017 ) Not 
named 
CHEOPS      no 60 72 144 
Canbulat et al. (2014 ) Parent & 
Clinician 
WBF      yes 188 84 132 
Cantekin et al. (2014 ) Parent & 
Clinician 
FLACC      no 78 48 120 
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Cao et al. (2011 ) Not 
named 
CHIPPS      no 59 72 96 
Casey et al. (1990 ) Researcher OPS      no 60 24 120 
Cassidy et al. (2001 ) Parent, 
Clinician & 
Researcher 
VAS CHEOPS CFCS    yes 161 48 72 
Cassidy et al. (2002) Researcher CHEOPS CFCS     yes 62 60 60 
Celebi et al. (2013 ) Clinician OPS      no 60 36 72 
Chadha et al. (2013 ) Parent & 
Researcher 
FLACC WBF     yes 69 36 144 
Chalam et al. (2015) Not 
named 
OPS      no 100 24 120 
Chambers et al. (1996 ) Parent PPM      yes 110 84 144 
Chambers et al. (1999 ) Parent PBCL FACES WBF MFACE KLPF  yes 75 60 144 
Chambers et al. (2003) Parent PPPM      yes 51 84 144 
Chambers et al. (2005 ) Parent & 
Clinician 
PBCL FACES CAS WBF MFACE KLPF yes 78 60 156 
Chambers, et al. (1997) Parent VAS      no 82 24 144 
Chandler et al. (2013 ) Researcher 
& Clinician 
FLACC      no 112 24 72 
Chang  (2005 ) Parent WBF      yes 101 24 192 
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Chang (2008 ) Parent WBF      yes 69 24 192 
Chang et al. (2015 ) Clinician CHEOPS FLACC CFCS TPPS RIPS PEPPS no 44 13 74 
Choi et al. (2003 ) Clinician CHEOPS      no 63 24 144 
Choi et al. (2016 ) Not 
named 
MAPS      no 41 13 60 
Choy et al. (1999 ) Parent & 
Clinician 
VAS/CAS?      yes 34 12 168 
Christiano et al. (1998 ) Parent TPPS      no 74 12 64 
Ciftci et al. (2014 ) Not 
named 
CHEOPS      no 52 12 204 
Cobb et al. (2009 ) Parent & 
Clinician 
VAS      yes 89 48 144 
Cohen et al. (1997 ) Parent, 
Clinician & 
Researcher 
VAS FACES     yes 62 48 72 
Cohen et al. (2004 ) Clinician VAS      yes 39 105.96 132.96 
Cohen et al. (2009 ) Parent, 
Clinician & 
Researcher 
VAS OWN     yes 57 48 72 
Cole et al. (2009 ) Clinician FLACC      no 46 12 36 
Cordoni et al. (2001 ) Clinician VAS      yes 57 48 144 
Costa et al. (2011 ) Researcher FLACC      no 160 16 83 
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Cregg et al. (1996 ) Researcher OPS      no 43 36 180 
Dak-Albab et al. (2016 ) Researcher FLACC      no 30 96 144 
Dal et al. (2007 ) Clinician OPS      no 90 24 144 
Dalens et al. (2001 ) Not 
named 
OPS CRS4     no 22 24 134.4 
Davis et al. (2000 ) Clinician OPDS      no 206 24 144 
De et al. (2004 ) Clinician CHIPPS      no 90 24 72 
De et al. (2010) Clinician FPSR CAS     yes 131 60 180 
de et al. (2014 ) Parent PPPM      yes 174 48 120 
De Gennaro et al. (2004 ) Not 
named 
CHEOPS      yes 10 48 204 
Deepika et al. (2012 ) Researcher SEM      yes 60 72 144 
Demiraran et al. (2006 ) Clinician WBF      no 75 12 72 
Depue et al. (2013 ) Parent, 
Clinician & 
Researcher 
FLACC VAS     no 91 24 84 
Dewhirst et al. (2014 ) Clinician FLACC OPS     no 99 12 92.4 
Disma et al. (2009 ) Researcher CHEOPS      no 73 12 72 
Duflo et al. (2004 ) Not 
named 
CHEOPS VAS     no 27 48 204 
El et al. (2011) Clinician FLACC      no 80 24 144 
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Elbay et al. (2016 ) Parent VAS      yes 40 72 144 
Eldeen et al. (2016) Not 
named 
CHEOPS      no 40 24 60 
El-Fattah et al. (2013 ) Parent PPPM      yes 135 60 144 
Elhakim et al. (2003 ) Researcher 
& Clinician 
VAS CHEOPS     yes 110 48 120 
El-Hamid et al. (2017 ) Clinician FLACC      no 86 36 84 
Elsey et al. (2017) Clinician OPS      no 17 24 216 
El-Sharkawi et al. (2012 ) Researcher FLACC      yes 48 60 84 
Eltzschig et al. (2002 ) Not 
named 
OPS      no 81 24 144 
Emmott et al. (2016 ) Researcher FLACC      yes 120 36 72 
Enyedi et al. (2017 ) Researcher CHEOPS      no 50 13 91 
Ericsson et al. (2006 ) Parent & 
Clinician 
CRS7      yes 92 60 180 
Erol et al. (2008 ) Clinician CHIPPS      no 40 12 84 
Ertugrul et al. (2006 ) Researcher TPPS      no 45 12 84 
Evans et al. (1995 ) Clinician CHEOPS      yes 30 48 180 
Faiz et al. (2013 ) Not 
named 
OPS      no 84 48 156 
Fallah et al. (2016 ) Not 
named 
MBPS      no 70 18 18 
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Faraoni et al. (2010 ) Clinician OPS      no 40 12 168 
Farion et al. (2008) Parent & 
Clinician 
CRS4      yes 80 72 144 
Farrag et al. (2015 ) Clinician VAS      no 40 36 120 
Fatovich et al. (1999 ) Parent & 
Clinician 
VAS OWN     no 136 12 120 
Fearon et al. (1996 ) Researcher DAL      no 56 28 81 
Feda et al. (2010 ) Researcher SEM      yes 40 84 131 
Fekih et al. (2013 ) Not 
named 
CHEOPS      no 75 12 72 
Fernandes et al. (2012 ) Not 
named 
FLACC      no 80 12 120 
Finley et al. (2003 ) Parent PPPM      yes 75 84 144 
Fishman et al. (2005 ) Parent & 
Clinician 
WBF      yes 24 24 144 
Foster et al. (2002 ) Parent VAS TQPM     yes 50 98.4 154.8 
Franck et al. (2015 ) Parent & 
Researcher 
FLACC FPSR     yes 76 48 72 
Furuya et al. (2009 ) Parent & 
Clinician 
FACES      no 73 72 180 
Galinkin et al. (2002 ) Parent & 
Researcher 
CHEOPS VAS     yes 22 84 192 
Gamis et al. (1989 ) Clinician CHEOPS      no 34 24 192 
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Gazal et al. (2007 ) Researcher CHEOPS      no 201 24 144 
Gedam et al. (2013 ) Researcher 
& Clinician 
FLACC      no 350 12 30 
Georgopoulos et al. (2012 ) Parent TQPM      yes 124 48 144 
Ghai et al. (2009 ) Researcher OPS      no 44 24 120 
Ghosh et al. (2011 ) Not 
named 
OPS      no 90 12 60 
Gilbert-MacLeod et al. (2000 
) 
Researcher DAL      no 60 24 72 
Girotra et al. (1990 ) Researcher CRS3      no 40 12 132 
Girwalkar-Bagle et al. (2015 ) Clinician CHIPPS      no 60 24 60 
Gomez et al. (2013 ) Researcher 
& Clinician 
FLACC      no 29 12 18 
Goodenough et al. (1997 ) Clinician GBCL      yes 10 48 81 
Goodenough et al. (1999 ) Parent VAS      yes 110 36 180 
Goodenough et al. (2000) Parent & 
Researcher 
FACES GBCL     yes 24 48 72 
Goodenough, et al. (1997 ) Researcher FACES      yes 121 36 204 
Goodenough, et al. (1998 ) Researcher FACES GBCL     yes 121 36 204 
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Goodman et al. (2003 ) Parent & 
Researcher 
FACES CFCS     yes 96 108 180 
Goubert et al. (2009 ) Parent & 
Researcher 
NRS11 CFCS     yes 53 110.04 180 
Granry et al. (1997 ) Clinician MFACE CRS4     yes 88 72 144 
Gunes et al. (2004 ) Clinician CHEOPS      no 99 12 120 
Gupta et al. (2014) Not 
named 
FLACC      no 70 12 84 
Gurkan et al. (2017 ) Clinician CHEOPS      no 75 16 72 
Ha et al. (2013 ) Parent & 
Researcher 
VAS PBCL     yes 84 36 120 
Hadi et al. (2015 ) Clinician OPS      no 92 36 84 
Halperin et al. (2000 ) Researcher MBPS      no  12 15.6 
Hamers et al. (1999 ) Parent, 
Clinician & 
Researcher 
CHEOPS FLACC VAS    yes 83 36 144 
Hamid et al. (2010 ) Researcher OWN      no 40 42 96 
Hartrick et al. (2002 ) Clinician TPPS FLACC COMFORT    no 51 13.2 61.32 
Hasani et al. (2011 ) Clinician OPS      no 45 12 108 
Hashizume et al. (2001 ) Clinician OPS      no 60 12 60 
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Hashizume et al. (2007 ) Clinician OPS      no 40 12 60 
Hay et al. (2009 ) Parent & 
Researcher 
WBF OWN     yes 23 48 216 
Hee et al. (2003 ) Clinician CHEOPS      yes 120 96 180 
Helgadottir et al. (2014 ) Parent PPPM      yes 93 36 84 
Hendrickson et al. (1990 ) Parent & 
Clinician 
VAS      yes 46 12 192 
Hennrikus et al. (1995 ) Clinician CHEOPS      yes 97 48 204 
Hesselgard et al. (2006 ) Clinician BOPS      no 26 32.4 88.8 
Hesselgard et al. (2007) Clinician BOPS CHEOPS     no 76 12 84 
Hiller et al. (2006 ) Researcher MAUN      no 120 12 108 
Hirschfeld et al. (2013 ) Parent VAS      no 2276 36 120 
Hoeffe et al. (2017 ) Researcher FLACC      yes 90 48 216 
Holthusen et al. (1994 ) Researcher CHEOPS      no 25 31.2 117.6 
Honarmand et al. (2008 ) Clinician CHEOPS      no 75 36 144 
Honarmand et al. (2013 ) Clinician CHEOPS      no 120 24 180 
Hong et al. (2017 ) Clinician CHEOPS      no 62 36 84 
Hopkins et al. (1988 ) Researcher OWN VAS     no 111 12 60 
Hosey et al. (2006 ) Clinician CHEOPS      no 407 27.6 177.6 
Hosten et al. (2011 ) Researcher CHEOPS      no 70 12 72 
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Hua et al. (2015 ) Parent & 
Clinician 
FLACC VAS     no 65 48 192 
Huet et al. (2011 ) Not 
named 
OPS      yes 30 60 144 
Huh et al. (2017 ) Clinician CHEOPS FLACC     no 75 36 120 
Hullett et al. (2009 ) Not 
named 
FLACC      no 51 12 36 
Hunt et al. (2004 ) Parent & 
Clinician 
PPP      no 140 12 216 
Inal et al. (2012 ) Parent & 
Clinician 
FPSR      yes 120 72 144 
Inal et al. (2012) Parent & 
Clinician 
FPSR      yes 123 72 144 
Inanoglu et al. (2009 ) Clinician CHEOPS      no 90 24 144 
Ipp et al. (2004 ) Parent, 
Clinician & 
Researcher 
VAS MPBS     no 49 12 12 
Ipp et al. (2006 ) Parent & 
Clinician 
VAS      yes 60 48 72 
Isaac et al. (2006 ) Researcher CHEOPS      no 14 12 96 
Ivani et al. (1996 ) Clinician OPS      no 42 12 120 
Ivani et al. (2000 ) Researcher OPS      no 40 12 84 
Ivani et al. (2002 ) Clinician OPS      no 40 12 84 
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Ivani et al. (2003 ) Clinician CHIPPS      no 60 12 84 
Ivani et al. (2005 ) Not 
named 
CHIPPS      no 60 12 84 
Jaaniste et al. (2007 ) Researcher CFCS      yes 78 84 144 
Jagannathan et al. (2009 ) Researcher CHIPPS      no 48 12 72 
Jamali et al. (1994 ) Clinician OPS      yes 45 12 84 
James et al. (2017) Clinician RCEM      yes 91 96 192 
Jensen et al. (2012 ) Parent VAS      yes 100 33.6 153.6 
Jeong et al. (2012 ) Not 
named 
CHEOPS      no 60 24 96 
Jongudomkarn et al. (2008 ) Parent & 
Clinician 
WBF NRS11 KKU    yes 150 72 144 
Joyce et al. (1994 ) Researcher PRS NAPI POPS    no 65 12 36 
Jylli et al. (1995 ) Parent & 
Clinician 
VAS      yes 129 36 192 
Kamath et al. (2013 ) Not 
named 
TPPS      no 56 48 60 
Kankkunen et al. (2003 ) Parent VAS PPPM     no 315 12 72 
Kankkunen et al. (2003) Parent PPPM VAS     no 315 12 72 
Kankkunen et al. (2009 ) Parent PPPM CRS5     no 50 12 35 
Kannojia et al. (2017 ) Not 
named 
CHEOPS      no 90 24 84 
Karaaslan et al. (2008 ) Clinician CHEOPS      no 75 36 144 
Karakoyunlu et al. (2015 ) Clinician OPS      no 60 24 132 
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Karamese et al. (2014 ) Not 
named 
CHEOPS      no 7 12 60 
Kawaraguchi et al. (2006 ) Clinician CHEOPS      no 36 36 84 
Kaya et al. (2012 ) Not 
named 
CHIPPS      no 60 12 120 
Kazak et al. (2010 ) Clinician FLACC OPS     no 60 24 72 
Keidan et al. (2003) Clinician NRS11      yes 31 36 180 
Keidan et al. (2005 ) Researcher FLACC      no 47 36 180 
Keller et al. (2006 ) Researcher UWCH      no 100 12 60 
Kelly et al. (2002 ) Parent VAS      yes 78 96 180 
Kelly et al. (2015 ) Parent & 
Researcher 
OPS      yes 91 12 120 
Kennedy et al. (1998 ) Parent VAS      no 260 60 180 
Khan et al. (2008 ) Not 
named 
TPPS      no 60 13 53 
Khosravi et al. (2006 ) Parent & 
Clinician 
CHEOPS CRS5     no 60 24 84 
Kim et al. (2003 ) Clinician CHEOPS      no 51 24 84 
Kim et al. (2011 ) Clinician CHEOPS      no 64 36 84 
Kim et al. (2012 ) Parent & 
Researcher 
VAS WBF     yes 42 60 120 
Kim et al. (2014 ) Parent & 
Clinician 
FLACC PPPM     no 80 24 72 
158 
 
Kim et al. (2017) Researcher FLACC      no 44 12 84 
Klein et al. (2002 ) Clinician CHEOPS      no 51 24 96 
Knutsson et al. (2006 ) Parent & 
Clinician 
VAS      yes 100 36 108 
Knutsson et al. (2006 ) Parent & 
Clinician 
VAS CHEOPS     no 295 18 24 
Kocum et al. (2013 ) Researcher CHEOPS      no 120 36 72 
Koinig et al. (1999 ) Clinician GOPS      no 56 18 84 
Kokki et al. (1999 ) Clinician MAUN      yes 59 12 144 
Kokki et al. (2003) Parent VAS PPPM     no 85 12 72 
Kokki et al. (2004) Clinician MAUN      yes 56 36 180 
Kokki et al. (2006 ) Not 
named 
MAUN      no 8 13 153 
Koner et al. (2011 ) Clinician CHIPPS      no 84 12 84 
Kotzer et al. (1998 ) Researcher CPS      yes 93 96 216 
Kreider et al. (2001 ) Clinician SEM      yes 32 72 180 
Kundra et al. (2006 ) Clinician APDS      no 132 24 144 
Lal et al. (2001 ) Parent & 
Clinician 
PMH      yes 27 48 96 
LaMontagne et al. (1991 ) Clinician VAS      yes 13 96 216 
Lassaletta et al. (1997) Clinician OWN      no 120 24 168 
Ledowski et al. (2017) Clinician FLACC      no 31 24 48 
Lee et al. (1996 ) Not 
named 
CHEOPS PBCL     yes 137 36 84 
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Lee et al. (2010) Clinician CHEOPS      no 93 24 168 
Lee et al. (2012 ) Not 
named 
CHEOPS      no 32 36 120 
Lee-Jayaram et al. (2010 ) Parent VAS      no 23 60 216 
Lejus et al. (2001) Clinician KRANE      no 261 24 0 
Leong et al. (2007) Researcher TPPS OPS     no 54 24 72 
Li et al. (2016 ) Clinician CHEOPS      no 60 36 84 
Li et al. (2017 ) Clinician CHEOPS      no 80 36 84 
Liang et al. (2014) Not 
named 
CHIPPS      no 90 36 84 
Lilley et al. (1997 ) Researcher NFCS BFACS     no 15 18 18 
Lin et al. (2009 ) Researcher CHEOPS      no 60 12 72 
Louw et al. (2016 ) Researcher CHEOPS      no 16 60 152 
Lullmann et al. (2010 ) Parent & 
Clinician 
VAS      yes 87 24 216 
Lundeberg et al. (2006 ) Researcher CHEOPS      no 40 12 24 
Luo et al. (2017 ) Clinician CHIPPS      no 93 12 60 
Maciocia et al. (2003 ) Parent & 
Clinician 
VAS WBF     yes 73 48 168 
Magaret et al. (2002) Parent WBF      yes 101 60 204 
Mahajan et al. (2004 ) Researcher OPS      no 80 24 96 
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Malmgren et al. (2004 ) Not 
named 
OPDS      no 82 24 72 
Marseglia et al. (2015) Not 
named 
FLACC      no ? 12 36 
Maryam et al. (2017) Clinician CHEOPS      no 80 60 144 
Massaro et al. (2014 ) Parent & 
Clinician 
CHEOPS NCCPC DESS    no 40 36 216 
Mattila et al. (2016 ) Clinician OPS      no 49 15.6 116.4 
Maunuksela et al. (1986 ) Clinician CRS4      yes 60 48 120 
Maunuksela et al. (1987 ) Parent MAUN MFACE     yes 141 19.2 211.2 
Maunuksela et al. (1988 ) Clinician MAUN      yes 100 12 192 
Maunuksela et al. (1992 ) Clinician MAUN      no 90 36 144 
Maunuksela et al. (1992 ) Clinician MAUN      yes 128 48 144 
McCarthy et al. (2000 ) Parent & 
Clinician 
TPPS VAS NRS10    no 100 12 60 
McCarty et al. (2000 ) Clinician CHEOPS      no 114 12 130 
McIntyre et al. (2012 ) Parent NRS11      no 178 24 96 
McJunkins et al. (2010 ) Parent & 
Clinician 
VAS MOPS CHEOPS NCCPC   no 11 36 144 
McWilliams et al. (2007 ) Clinician CHEOPS      no 74 24 72 
Memis et al. (2003 ) Clinician TPPS      no 45 12 60 
Mikawa et al. (1996 ) Researcher OPS      no 90 60 144 
Mikawa et al. (1997 ) Researcher OPS      no 90 24 132 
Miller et al. (2010 ) Parent & 
Clinician 
FLACC VAS     yes 80 36 120 
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Min et al. (2012 ) Clinician CHEOPS      no 44 36 156 
Miner et al. (2007 ) Clinician CHEOPS      no  18 72 
Minute et al. (2012 ) Researcher FLACC      yes 97 48 120 
Mitrakul et al. (2015 ) Clinician FLACC      yes 42 60 96 
Mittal et al. (2015 ) Clinician MBPS      yes 102 60 144 
Moadad et al. (2016 ) Parent & 
Clinician 
WBF      yes 48 48 144 
Modaresi et al. (1996 ) Researcher IZF      yes 30 93.6 188.4 
Mohamed (2015) Not 
named 
CHEOPS      no 48 18 36 
Mohan et al. (2015 ) Clinician FLACC WBF     yes 123 48 180 
Mohebbi et al. (2014 ) Parent VAS      no 80 60 180 
Moir et al. (2000 ) Parent WBF      yes 51 36 144 
Moon et al. (2008 ) Parent FACES      yes 73 48 144 
Morgan et al. (2001 ) Parent & 
Clinician 
OWN      no 42 12 58.8 
Morteza et al. (2012) Not 
named 
CHEOPS      no 70 60 180 
Mott et al. (2008 ) Parent VAS      yes 42 36 168 
Movahedi et al. (2007 ) Not 
named 
CHEOPS      yes 80 72 144 
Munro et al. (1994 ) Clinician OWN      no 42 24 108 
Murray et al. (1987) Clinician OWN      no 40 48 156 
Nader et al. (2004 ) Researcher FACES CFCS     no 43 37.2 94.2 
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Naja et al. (2013 ) Clinician OPS      no 80 24 60 
Nicodemus et al. (1991 ) Clinician OWN      yes 60 24 156 
Nilsson et al. (2008 ) Parent FLACC      yes 80 60 192 
Nilsson et al. (2009 ) Clinician FLACC      yes 80 84 192 
Nishina et al. (2000 ) Researcher OPS      no 125 24 144 
Noel et al. (2015 ) Parent NRS11      no 49 120 216 
Noel et al. (2017 ) Parent NRS11      no 66 120 216 
Noguchi(2006 ) Researcher FACES      yes 64 48 78 
Norambuena et al. (2013 ) Researcher CHEOPS      no 60 12 60 
Numanoglu et al. (2014 ) Clinician OPS      yes 52 24 84 
Nyman et al. (2005 ) Clinician CRS4      no 83 24 216 
O'Brien et al. (2004 ) Researcher MBPS      no 120 12 12 
Odabas et al. (2012 ) Researcher MBPS      yes 50 84 156 
O'Flaherty et al. (2003 ) Clinician OPS      no 80 36 144 
Ohashi et al. (2016 ) Clinician BOPS      no 40 12 72 
Oksuz et al. (2017 ) Clinician FLACC      no 53 12 84 
Olanipekun et al. (2015 ) Parent FLACC VAS     no 62 12 84 
Ozbek et al. (2002 ) Clinician CHEOPS      no 109 12 108 
Ozyuvaci et al. (2004 ) Researcher CHEOPS      no 60 36 144 
Pan et al. (2005 ) Clinician VPS      no 100 60 120 
Parameswari et al. (2010 ) Clinician FLACC      no 100 12 36 
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Park et al. (2004 ) Clinician CRS4      no 130 24 144 
Paschos et al. (2006 ) Clinician CHEOPS SEM     yes 104 60 144 
Passariello et al. (2004 ) Clinician CHEOPS      no 44 12 66 
Paut et al. (2001 ) Researcher OPS      yes 40 72 132 
Peden et al. (2003 ) Clinician TPPS DPT     no 40 12 60 
Peden et al. (2005 ) Clinician DPT      yes 64 72 144 
Pickford et al. (2000) Clinician CRS4      no 69 36 120 
Pierce et al. (1997 ) Clinician CHEOPS      no 35 36 216 
Pieters et al. (2010 ) Parent & 
Clinician 
CHEOPS NRS11     no 42 36 84 
Potts et al. (2017) Not 
named 
FLACC      yes 224 48 216 
Pour et al. (2017 ) Clinician FLACC      no 120 72 144 
Primosch et al. (2001 ) Clinician CHEOPS      yes 40 89 191 
Prosser et al. (1997 ) Clinician TPPS      no 90 13 53 
Purday et al. (1996 ) Researcher OPS      no 120 24 120 
Rabbitts et al. (2015 ) Parent NRS11      no 915 24 216 
Ragg et al. (2017 ) Parent NRS11      yes 100 72 216 
Rai et al. (2014 ) Not 
named 
SEM      yes 60 72 168 
Rajasagaram et al. (2009) Parent & 
Clinician 
NRS11      yes 86 36 180 
Ram et al. (2003 ) Clinician MBPS      no 102 36 120 
Ram et al. (2006 ) Clinician MBPS      yes 62 60 156 
Ramirez et al. (2015 ) Clinician CHEOPS      no 69 24 84 
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Ramirez-Carrasco et al. 
(2017 ) 
Clinician FLACC      no 40 60 108 
Rattaz et al. (2013 ) Researcher NCCPC CFCS     no 67 36 96 
Redmann et al. (2017 ) Clinician FLACC      no 125 36 144 
Reid et al. (1987 ) Clinician VAS      no 49 12 84 
Reid, et al. (1995) Parent VAS      no 176 24 144 
Rice et al. (1990 ) Researcher OPS      no 40 18 132 
Riddell et al. (2004 ) Parent VAS      no 49 12 18 
Rieger et al. (1996 ) Researcher OPS      no 41 24 120 
Risaw et al. (2017) Parent & 
Clinician 
FLACC WBF     yes 210 48 72 
Ritterman et al. (2014 ) Not 
named 
FLACC      no 7 22 36 
Rizk et al. (2014) Not 
named 
OPS      no 90 36 72 
Rocha et al. (2003 ) Researcher FACS      no 163 56 68 
Romsing, et al. (1996 ) Parent VAS      yes 100 36 180 
Ronnerfalt et al. (1998 ) Clinician CRS4      yes 29 48 108 
Rosales et al. (2016 ) Parent PPPM      no 161 24 180 
Rose et al. (1999 ) Parent & 
Clinician 
VAS CHEOPS     yes 57 72 144 
Rubinstein et al. (2016 ) Parent & 
Clinician 
VAS VAS     no 68 12 120 
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Sadhasivam et al. (2014 ) Clinician FLACC      yes 149 72 180 
Sakellaris et al. (2004 ) Researcher OPS      no 45 72 120 
Salgado et al. (2013 ) Clinician VAS      no 41 24 156 
Sammons et al. (2007 ) Researcher TPPS      yes 86 24 60 
Sandeep et al. (2016 ) Researcher SEM      yes 100 84 156 
Sanders et al. (2007 ) Parent & 
Clinician 
VAS      no 53 18 48 
Sargin et al. (2015 ) Not 
named 
NCCPC      no 40 72 192 
Sato et al. (2010 ) Researcher CHIPPS      no 81 12 108 
Saxena et al. (2014 ) Not 
named 
FLACC      no 70 12 84 
Saylan et al. (2014) Not 
named 
CHIPPS      no 40 24 120 
Schmitz et al. (2015 ) Parent VAS      yes 535 36 216 
Schneider, et al. (1992 ) Parent & 
Clinician 
OUCHER      yes 42 35 78 
Schultz et al. (1999 ) Clinician PEPPS      no 40 12 24 
Schutzman et al. (1996 ) Researcher CHEOPS      no 39 36 96 
Sen et al. (2014) Not 
named 
CHIPPS      no 60 18 84 
Senel et al. (2001 ) Clinician CRS3      no 60 12 84 
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Sermet et al. (2016 ) Not 
named 
FLACC      yes 60 72 144 
Sethna et al. (2005 ) Clinician CRS4      yes 64 36 204 
Sezen et al. (2014) Clinician CHIPPS      no 68 24 84 
Shaikh et al. (2015 ) Not 
named 
FLACC      no 60 12 144 
Shamim et al. (2015 ) Parent & 
Clinician 
CHEOPS TPPS FLACC OPS   no 25 36 84 
Shavit et al. (2008 ) Clinician AHPS      yes 75 36 180 
Shehab et al. (2015 ) Researcher SEM      yes 100 108 144 
Shi et al. (2017 ) Not 
named 
FLACC      no 178 36 144 
Shirazi et al. (2016 ) Clinician FLACC      no 42 12 72 
Siddiqui et al. (2013 ) Clinician CHEOPS      no 75 60 144 
Sikka et al. (2015 ) Parent & 
Clinician 
NRS11      yes 50 60 216 
Sikorova et al. (2011 ) Clinician CHEOPS      yes 60 60 120 
Singer et al. (2002) Parent & 
Clinician 
VAS      yes 63 48 84 
Singh et al. (2012 ) Clinician FLACC      no 90 12 120 
Singh et al. (2012 ) Clinician FLACC      no 80 12 120 
Sinha et al. (2006 ) Parent VAS      yes 240 72 216 
Sinha et al. (2009 ) Not 
named 
OPS      no 96 36 144 
Sixou et al. (2009 ) Clinician VAS      yes 50 72 192 
Smith et al. (1979 ) Clinician CRS5      yes 212 180 204 
167 
 
Smith et al. (1997 ) Parent, 
Clinician & 
Researcher 
VAS      yes 240 12 216 
Smith et al. (1998 ) Parent, 
Clinician & 
Researcher 
VAS      yes 40 12 204 
Smith et al. (2009) Clinician FLACC      no 178 84 144 
Soetenga et al. (1999 ) Parent & 
Clinician 
UWCH WBF     no 15 24 192 
Sola et al. (2014 ) Parent & 
Clinician 
PPPM FLACC     no 27 12 60 
Solodiuk (2013 ) Parent, 
Clinician & 
Researcher 
INRS FLACC PPP PIPP UWCH NCCPC no 50 0 0 
Solodiuk et al. (2010 ) Parent, 
Clinician & 
Researcher 
INRS NCCPC     no 50 72 216 
Soltesz et al. (2007 ) Researcher OWN      no 64 24 72 
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Somaini et al. (2016 ) Researcher FLACC CHIPPS CHEOPS    no 512 12 72 
Spanos et al. (2008 ) Parent & 
Researcher 
VAS      yes 70 96 180 
Spektor et al. (2016 ) Parent CHIPPS      no 100 36 144 
Splinter et al. (1995 ) Clinician CHEOPS      no 156 18 156 
Splinter et al. (1995 ) Parent & 
Researcher 
CHEOPS VAS     no 202 12 156 
Splinter et al. (1997 ) Parent & 
Clinician 
VAS CHEOPS     no 164 24 72 
Steib et al. (2005 ) Clinician CHEOPS      no 38 30 72 
St-Laurent-Gagnon et al. 
(1999) 
Parent FAS HPCT MSPCT    yes 104 48 72 
Stoddard et al. (2006 ) Clinician WBF      no  12 48 
Strout et al. (2011 ) Clinician PEPPS      no 118 12 38 
Strout et al. (2011) Clinician MPEPPS      no 118 12 36 
Study et al. (2015 ) Researcher TDI      no 943 18 36 
Subhashini et al. (2008 ) Parent & 
Clinician 
WBF CAS     yes 181 72 144 
Suraseranivongse et al. 
(2003 ) 
Clinician CHEOPS      no 103 12 144 
Suresh et al. (2002 ) Researcher OPS      no 40 24 216 
Sutters et al. (1999 ) Clinician CHEOPS      yes 87 36 144 
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Sutters et al. (2012 ) Parent FLACC      no 47 36 60 
Sylvester et al. (2011 ) Clinician CHEOPS      no 87 33 141 
Taddio et al. (2009) Researcher 
& Clinician 
VAS MBPS     no 120 12 12 
Taddio et al. (2017 ) Parent, 
Clinician & 
Researcher 
MBPS NRS11     no 296 15 15 
Taheri et al. (2011 ) Clinician OPS      no 60 36 144 
Talu et al. (2008) Not 
named 
OPS      no 60 12 144 
Tan et al. (1992) Clinician VAS      yes 73 60 180 
Tarbell et al. (1992) Parent, 
Clinician & 
Researcher 
TPPS VAS NRS    no 74 12 64 
Tay et al. (2012 ) Parent NRS10      no 41 12 180 
Tazeroualti et al. (2007 ) Researcher OPS      no 68 12 72 
Tekelioglu et al. (2013 ) Clinician WBF      no 60 48 120 
Teo et al. (2011 ) Clinician FLACC      no 52 24 190.8 
Thompson et al. (2012 ) Parent PPPM      no 202 48 216 
Toker et al. (2016 ) Clinician CHIPPS      no 75 24 84 
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Trifa et al. (2009) Not 
named 
CHEOPS      no 72 36 108 
Trifa et al. (2012 ) Not 
named 
CHEOPS      no 60 12 72 
Tripi et al. (2005 ) Not 
named 
WBF FLACC     no 35 12 120 
Tsao et al. (2015 ) Parent WBF      yes 59 36 144 
Tsuchiya et al. (2004 ) Parent WBF      no 30 12 96 
Tuomilehto et al. (2000 ) Clinician MAUN      no 100 12 108 
Tuomilehto et al. (2002 ) Clinician MAUN      no 120 12 108 
Turan et al. (2003 ) Clinician TPPS      no 44 12 60 
Tyler et al. (1993 ) Not 
named 
CHEOPS  CRS5    yes 26 36 144 
Ugur et al. (2013 ) Not 
named 
CHEOPS      no 75 36 120 
Ullan et al. (2014 ) Not 
named 
FLACC      no 95 12 84 
Umuroglu et al. (2004 ) Researcher CHEOPS      yes 60 60 144 
Usichenko et al. (2016 ) Parent & 
Clinician 
 NRS11     yes 72 48 216 
Uysal et al. (2011 ) Clinician OPS      no 64 72 192 
van der Putten et al. (2011 ) Parent & 
Researcher 
VAS PBC     no 16 36 84 
van Dijk et al. (2001 ) Clinician COMFORT VAS     no 40 12 36 
van Dijk et al. (2002 ) Clinician COMFORT VAS     no 35 12 36 
171 
 
Varghese et al. (2010 ) Researcher CRS4      no 84 60 180 
Versloot et al. (2004 ) Parent, 
Clinician & 
Researcher 
CRS4      no 50 48 96 
Vessey, et al. (1994) Researcher CHEOPS      yes 100 42 155 
Vetter et al. (1996 ) Parent & 
Clinician 
NRS101      yes 30 96 192 
Viitanen et al. (1999 ) Clinician OPS      no 60 12 36 
Viitanen et al. (1999 ) Clinician OPS      no 52 12 36 
Viitanen et al. (2000 ) Clinician OPS      no 80 12 36 
Viitanen et al. (2001 ) Clinician OPS      no 80 12 36 
Viitanen et al. (2003 ) Clinician OPS      no 160 12 72 
Voepel-Lewis et al. (2002) Parent, 
Clinician & 
Researcher 
FLACC VAS     yes 79 48 216 
von Baeyer et al. (2011 ) Parent PPPM      yes 264 84 144 
von et al. (2011 ) Parent FPSR      yes 108 36 84 
Walther-Larsen et al. (2016 ) Parent PPPM NRS11     no 149 12 204 
Watcha et al. (1992 ) Researcher OPS      yes 95 60 180 
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Wathen et al. (2007 ) Researcher FLACC CHEOPS     yes 120 15 216 
Werk et al. (2008 ) Clinician OPS FPSR     yes 62 60 204 
Wheeler et al. (2005 ) Researcher OPS      no 30 24 103.2 
Whitehead-Pleaux et al. 
(2006 ) 
Clinician NAPI      yes 14 72 192 
Wolf et al. (2002 ) Clinician CRS4      yes 125 48 144 
Wong et al. (2015 ) Parent  PPPM     yes 33 48 72 
Xiang et al. (2014 ) Clinician FLACC      no 50 12 36 
Yao et al. (2017) Researcher FLACC      no 28 12 72 
Yeh et al. (2005 ) Not 
named 
FLACC      yes 149 36 83.04 
Yenigun et al. (2015 ) Researcher CHEOPS      no 120 60 180 
Yenigun et al. (2018) Researcher CHEOPS      no 63 24 168 
Yildiz et al. (2010 ) Clinician CHIPPS      no 63 12 84 
Yilmaz et al. (2014 ) Clinician CHEOPS      no 537 16 19 
Yinger et al. (Winter, ) Parent UPAT      no 58 48 72 
Young, et al. (1988) Researcher OWN      no 80 48 83 
Yu et al. (2015 ) Clinician CRS4      no 100 36 144 
Zanchi et al. (2017) Parent & 
Clinician 
NCCPC      no 40 36 216 
Zavras et al. (2014) Clinician FLACC      no 106 24 144 
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Zempsky et al. (2003 ) Parent, 
Clinician & 
Researcher 
VAS      yes 42 84 216 
Zempsky et al. (2004 ) Parent WBF      yes 86 60 132 
Zempsky et al. (2008 ) Parent VAS      yes 579 36 216 
Zempsky et al. (2008 ) Parent VAS      yes 60 36 84 
Zhang et al. (2014 ) Clinician CHEOPS      yes 61 48 192 
Zhao et al. (2012 ) Clinician CAM4      no 192 36 120 
Zhuang et al. (2011 ) Clinician CHEOPS      no 60 24 156 
Zisk et al. (2007 ) Parent PPPM      yes 32 60 120 
 
 
 
